Environmental health criteria for transgenic animal mutagenicity assays

Environmental Health Criteria

Volumn , Issue 233, 2006, Pages

  Chen, T ^a   Dean, S ^b   Douglas, G R ^c   Heddle, J A ^d   Lambert, I B ^e   Nohmi, T ^f   Sykes, P J ^g   Thybaud, V ^h   Valentine, C R ^a   Van Benthem, J ⁱ   Bitsch, A ^j   Kielhorn, J ^j   Mangelsdorf, I ^j   Vickers, C ^k   Wahnschaffe, U ^j  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b HUNTINGDON LIFE SCIENCES   (United Kingdom)

^c Environmental Health Center   (Canada)

^d YORK UNIVERSITY   (Canada)

^e CARLETON UNIVERSITY   (Canada)

^f NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^g FLINDERS UNIVERSITY   (Australia)

^h Paris Research Center   (France)

ⁱ NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^j FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^k WORLD HEALTH ORGANIZATION   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOASSAY; CELLS; DETECTORS; DNA; DRUG DOSAGE; OPTIMIZATION; TOXICITY;

EXOGENOUS GENE; MUTATION FREQUENCY; RODENT EMBRYO; TRANSGENIC MUTAGENICITY ASSAYS;

MUTAGENESIS;

1,2 DIBROMOETHANE; 1,2 DICHLOROETHANE; 1,3 BUTADIENE; 2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; 2 AMINO 3,8 DIMETHYLIMIDAZO[4,5 F]QUINOXALINE; 2,4 DIAMINOTOLUENE; 2,6 DIAMINOTOLUENE; 4 BIPHENYLAMINE; ACRYLAMIDE; ADENINE PHOSPHORIBOSYLTRANSFERASE; AFLATOXIN B; ASBESTOS; BENZENE; BENZO[A]PYRENE; CHLORAMBUCIL; CHLOROFORM; CYCLOPHOSPHAMIDE; ETHYLENE OXIDE; ETHYLNITROSOUREA; HEPTACHLOR; HYDRAZINE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MESYLIC ACID ETHYL ESTER; METHYL BROMIDE; N (2 FLUORENYL)ACETAMIDE; TAMOXIFEN; THIOTEPA; THYMIDINE KINASE; UNINDEXED DRUG;

CARCINOGENICITY; CHROMOSOME ABERRATION; DNA DAMAGE; DNA ISOLATION; DNA SEQUENCE; DOSE RESPONSE; GENE DELETION; GENE LOCUS; GENE MUTATION; GENETIC TOXICOLOGY; GENOTOXICITY; INTERMETHOD COMPARISON; MUTAGEN TESTING; MUTAGENICITY; MUTATION RATE; NONHUMAN; REVIEW; RISK ASSESSMENT;

ANIMALIA; MUS; MUS MUSCULUS; RATTUS; RODENTIA;

EID: 33847096900     PISSN: 0250863X     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (451)

1. ACGIH (1998) β-Propiolactone. In: Documentation of the threshold limit values (TLV) and biological exposure indices (BEI). Cincinnati, Ohio, American Conference of Governmental Industrial Hygienists, pp 1292-1293.
2. Adler I-D, Cao J, Filser JG, Gassner P, Kessler W, Kliesch U, Neuhäuser-Klaus A & Nüsse M (1994) Mutagenicity of 1,3-butadiene inhalation in somatic and germinal cells of mice. Mutat Res, 309(2): 307-314.
3. Albanese R, Mirkova E, Gatehouse D & Ashby J (1988) Species-specific response to the rodent carcinogens 1,2-dimethylhydrazine and 1,2-dibromo-3-chloropropane in rodent bone-marrow micronucleus assays. Mutagenesis, 3(1): 35-38.
4. Arai T, Kelly VP, Minowa O, Noda T & Nishimura S (2002) High accumulation of oxidative DNA damage, 8-hydroxyguanine, in Mmh/Ogg1 deficient mice by chronic oxidative stress. Carcinogenesis, 23: 2005-2010.
5. Arai T, Kelly VP, Komoro K, Minowa O, Noda T & Nishimura S (2003) Cell proliferation in liver of Mmh/Ogg1-deficient mice enhances mutation frequency because of the presence of 8-hydroxyguanine in DNA. Cancer Res, 63: 4287-4292.
6. Araki A, Kato F, Matsushima T, Ikawa N & Nozaki K (1995) Micronuclei induction of methyl bromide in rats and mice by sub-chronic inhalation toxicity test. Environ Mutagen Res Commun, 17(1): 47-56.
7. Arlt VM, Zhan L, Schmeiser HH, Honma M, Hayashi M, Phillips DH & Suzuki T (2004) DNA adducts and mutagenic specificity of the ubiquitous environmental pollutant 3-nitrobenzanthrone in Muta™Mouse. Environ Mol Mutagen, 43(3): 186-195.
8. - mutation data for DMBA and its K-region sulphur isostere: comparison with activities observed in standard genotoxicity assays. Mutat Res, 292: 25-40.
9. 32P bladder DNA adduction. Carcinogenesis, 15(10): 2291-2296.
10. Ashby J, Gorelick NJ & Shelby MD (1997) Mutation assays in male germ cells from transgenic mice: overview of study and conclusions. Mutat Res, 388: 111-122.
11. Asita AO, Hayashi M, Kodama Y, Matsuoka A, Suzuki T & Sofuni T (1992) Micronucleated reticulocyte induction by ethylating agents in mice. Mutat Res, 271: 29-37.
12. Autrup H, Jorgensen ECB & Jensen O (1996) Aflatoxin B1 induced lacI mutation in liver and kidney of transgenic mice C57BL/6N: effect of phorone. Mutagenesis, 11: 69-73.
13. Bastlová T, Andersson B, Lambert B & Kolman A (1993) Molecular analysis of ethylene oxide-induced mutations at the HPRT locus in human diploid fibroblasts. Mutat Res, 287: 283-292.
14. Belitsky GA, Lytcheva TA, Khitrovo IA, Safaev RD, Zhurkov VS, Vyskubenko IF, Sytshova LP, Salamatova OG, Feldt EG, Khudoley W, Mizgirev IV, Khovanova EM, Ugnivenko EG, Tanirbergenov TB, Malinovskaya KI, Revazova YA, Ingel FI, Bratslavsky VA, Terentyev AB, Shapiro AA & Williams GM (1994) Genotoxicity and carcinogenicity testing of 1,2-dibromopropane and 1,1,3-tribromopropane in comparison to 1,2-dibromo-3-chloropropane. Cell Biol Toxicol, 10: 265-279.
15. Besaratinia A & Pfeifer GP (2003) Weak yet distinct mutagenicity of acrylamide in mammalian cells. J Natl Cancer Inst, 95(12): 889-896.
16. Besaratinia A & Pfeifer GP (2004) Genotoxicity of acrylamide and glycidamide. J Natl Cancer Inst, 96(13): 1023-1029.
17. Besaratinia A, Synold TW, Xi B & Pfeifer GP (2004) G-to-T transversions and small tandem base deletions are hallmark of mutations induced by ultraviolet A radiation in mammalian cells. Biochemistry (Washington), 43(25): 8169-8177.
18. Bielas JH (2002) A more efficient Big Blue® protocol improves transgene rescue and accuracy in an adduct and mutation measurement. Mutat Res, 518(2): 107-112.
19. Bielas JH & Heddle JA (2000) Proliferation is necessary for both repair and mutation in transgenic mouse cells. Proc Natl Acad Sci USA, 97(21): 11391-11396.
20. Blakey DH, Douglas GR, Huang KC & Winter HI (1995) Cytogenetic mapping of lambda gt10 lacZ sequences in transgenic mouse strain 40.6 (Muta™Mouse). Mutagenesis, 10: 145-148.
21. Boerrigter ME (1999) Treatment of lacZ plasmid-based transgenic mice with benzo[a]pyrene: measurement of DNA adduct levels, mutant frequencies, and mutant spectra. Environ Mol Mutagen, 34: 140-147.
22. Boerrigter METI, Dollé MET, Martus H-J, Gossen JA & Vijg J (1995) Plasmid-based transgenic mouse model for studying in vivo mutations. Nature, 377: 657-659.
23. Bol SA, Horlbeck J, Markovic J, de Boer JG, Turesky RJ & Constable A (2000) Mutational analysis of the liver, colon and kidney of Big Blue® rats treated with 2-amino-3-methylimidazo[4,5-f]quinoline. Carcinogenesis, 21: 1-6.
24. Boyiri T, Guttenplan J, Khmelnitsky M, Kosinska W, Lin JM, Desai D, Amin S, Pittman B & El-Bayoumy K (2004) Mammary carcinogenesis and molecular analysis of in vivo cII gene mutations in the mammary tissue of female transgenic rats treated with the environmental pollutant 6-nitrochrysene. Carcinogenesis, 25(4): 637-643.
25. Brault D, Bouilly C, Renault D & Thybaud V (1996) Tissue-specific induction of mutations by acute oral administration of N-methyl-N′-nitro-N-nitrosoguanidine and β-propiolactone to the Muta™Mouse: preliminary data on stomach, liver and bone marrow. Mutat Res, 360: 83-87.
26. Brooks TM & Dean SW (1996) Detection of gene mutation in skin, stomach and liver of Muta™Mouse following oral or topical treatment with N-methyl-N′-nitro-N-nitrosoguanidine or 1-chloromethylpyrene: some preliminary observations. Mutagenesis, 11: 529-532.
27. Brooks TM & Dean SW (1997) The detection of gene mutation in the tubular sperm of Muta™Mice following a single intraperitoneal treatment with methyl methanesulphonate or ethylnitrosourea. Mutat Res, 388: 219-222.
28. Brooks TM, Szegedi M, Rosher P & Dean SW (1995) The detection of gene mutation in transgenic mice (Muta™Mouse) following a single oral dose of 2-acetylaminofluorene. Mutagenesis, 10: 149-150.
29. BUA (1996) Hydrazin, Hydrazinhydrat und Hydrazinsulfate. Beratergremium für umweltrelevante Altstoffe. Stuttgart, S. Hirzel Wissenschaftliche Verlagsgesellschaft, pp 1-179 (BUA Report No. 205).
30. Buettner VL, Nishino H, Haavik J, Knoll A, Hill K & Sommer SS (1997) Spontaneous mutation frequencies and spectra in p53(+/+) and p53(-/-) mice: a test of the "guardian of the genome" hypothesis in the Big Blue® transgenic mouse mutation detection system. Mutat Res, 379(1): 13-20.
31. Buettner VL, Hill KA, Halangoda A & Sommer SS (1999) Tandem-base mutations occur in mouse liver and adipose tissue preferentially as G:C→T:A transversions and accumulate with age. Environ Mol Mutagen, 33(4): 320-324.
32. Burkhart JG, Burkhart BA, Sampson KS & Malling HV (1993) ENU-induced mutagenesis at a single A-T base pair in transgenic mice containing Phi-X174. Mutat Res, 292: 69-81.
33. Butterworth BE, Templin MV, Constan AA, Sprankle CS, Wong BA, Pluta LJ, Everitt JI & Recio L (1998) Long-term mutagenicity studies with chloroform and dimethylnitrosamine in female lacI transgenic B6C3F1 mice. Environ Mol Mutagen, 31: 248-256.
34. Cariello NF, Douglas GR, Gorelick NJ, Hart DW, Wilson JD & Soussi T (1998) Databases and software for the analysis of mutations in the human p53 gene, human hprt gene and both the lacI and lacZ gene in transgenic rodents. Nucl Acids Res, 26: 198-199.
35. Carr GJ & Gorelick NJ (1994) Statistical tests of significance in transgenic mutation assays: considerations on the experimental unit. Environ Mol Mutagen, 24(4): 276-282.
36. Carr GJ & Gorelick NJ (1995) Statistical design and analysis of mutation studies in transgenic mice. Environ Mol Mutagen, 25(3): 246-255.
37. Carr GJ & Gorelick NJ (1996) A place for statistics in the generation and analysis of genetic toxicity data: a response to "rodent mutation assay data presentation and statistical assessment." Mutat Res, 357(1-2): 257-260.
38. Casciano DA, Aidoo A, Chen T, Mittelstaedt RA, Manjanatha MG & Heflich RH (1999) Hprt mutant frequency and molecular analysis of Hprt mutations in rats treated with mutagenic carcinogens. Mutat Res, 431: 389-395.
39. CCRIS (1995a) 4-Acetylaminofluorene. CAS: 28322-02-3. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Chemical Carcinogenesis Research Information System (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?CCRIS).
40. CCRIS (1995b) Beta-Propiolactone. CAS: 57-57-8. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Chemical Carcinogenesis Research Information System (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?CCRIS).
41. CCRIS (1995c) Chlorambucil. CAS: 305-03-3. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Chemical Carcinogenesis Research Information System (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?CCRIS).
42. CCRIS (1996) Acrylamide. CAS: 79-06-1. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Chemical Carcinogenesis Research Information System (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?CCRIS).
43. CCRIS (2000) N-Propyl-N-nitrosourea. CAS: 816-57-9. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Chemical Carcinogenesis Research Information System (http://toxnet.nlm.nih.gov/cgi-bin/ sis/htmlgen?CCRIS).
44. CCRIS (2001a) Ethyl methanesulfonate. CAS: 62-50-0. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Chemical Carcinogenesis Research Information System (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?CCRIS).
45. CCRIS (2001b) Methyl bromide. CAS: 74-83-9. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Chemical Carcinogenesis Research Information System (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?CCRIS).
46. CCRIS (2001c) Tris(2,3-Dibromopropyl)phosphate. CAS: 126-72-7. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Chemical Carcinogenesis Research Information System (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen? CCRIS).
47. CCRIS (2001d) Tamoxifen. CAS: 10540-29-1. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Chemical Carcinogenesis Research Information System (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?CCRIS).
48. CCRIS (2002a) 7,12-Dimethylbenz[a]anthracene. CAS: 57-97-6. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Chemical Carcinogenesis Research Information System (http://toxnet.nlm.nih.gov/cgi-bin/ sis/htmlgen?CCRIS).
49. CCRIS (2002b) Mitomycin C. CAS: 50-07-7. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Chemical Carcinogenesis Research Information System (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?CCRIS).
50. CCRIS (2002c) N,N-Dipropylnitrosamine. CAS: 621-64-7. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Chemical Carcinogenesis Research Information System (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen? CCRIS).
51. CCRIS (2003a) 4-Aminobiphenyl. CAS: 92-67-1. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Chemical Carcinogenesis Research Information System (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?CCRIS).
52. CCRIS (2003b) 4-Nitroquinoline 1-oxide. CAS: 56-57-5. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Chemical Carcinogenesis Research Information System (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?CCRIS).
53. CCRIS (2003c) Benzo[a]pyrene. CAS: 50-32-8. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Chemical Carcinogenesis Research Information System (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?CCRIS).
54. CCRIS (2003d) N,N-Diethylnitrosamine. CAS: 55-18-5. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Chemical Carcinogenesis Research Information System (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen? CCRIS).
55. CCRIS (2003e) Quinoline. CAS: 91-22-5. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Chemical Carcinogenesis Research Information System (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?CCRIS).
56. CCRIS (2003f) 4-(N-Methyl-N-nitrosamino)-1-(3-pyridyl)-1- butanone. CAS: 64091-91-4. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Chemical Carcinogenesis Research Information System (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?CCRIS).
57. Chang PY, Mirsalis J, Riccio ES, Bakke JP, Lee PS, Shimon J, Phillips S, Fairchild D, Hara Y & Crowell JA (2003) Genotoxicity and toxicity of the potential cancer-preventive agent polyphenon E. Environ Mol Mutagen, 41: 43-54.
58. Chen JB, Dobrovolsky VN & Heflich RH (1999) Development of a mouse cell line containing the ΦX174 am3 allele as a target for detecting mutation. Mutat Res, 444: 347-353.
59. Chen T, Aidoo A, Manjanatha MG, Mittelstaedt RA, Shelton SD, Lyn-Cook LE, Casciano DA & Heflich RH (1998) Comparison of mutant frequencies and types of mutations induced by thiotepa in the endogenous Hprt gene and transgenic lacI gene of Big Blue® rats. Mutat Res, 403: 199-214.
60. Chen T, Mittelstaedt RA, Aidoo A, Hamilton LP, Beland FA, Casciano DA & Heflich RH (2001a) Comparison of Hprt and lacI mutant frequency with DNA adduct formation in N-hydroxy-2-acetylaminofluorene- treated Big Blue® rats. Environ Mol Mutagen, 37(3): 195-202.
61. Chen T, Mittelstaedt RA, Shelton SD, Balachandra Dass S, Manjanatha MG, Casciano DA & Heflich RH (2001b) Gene- and tissue-specificity of mutation in Big Blue rats treated with the hepatocarcinogen N-hydroxy-2- acetylaminofluorene. Environ Mol Mutagen, 37(3): 203-214.
62. Chen T, Gamboa da Costa G, Marques MM, Shelton SD, Beland FA & Manjanatha MG (2002) Mutations induced by α-hydroxytamoxifen in the lacI and cII genes of Big Blue® transgenic rats. Carcinogenesis, 23(10): 1751-1757.
63. Cole J & Skopek TR (1994) Somatic mutant frequency, mutation rates and mutational spectra in the human population in vivo. Mutat Res, 304: 33-105.
64. Cosentino L & Heddle JA (1999) A comparison of the effects of diverse mutagens at the lacZ transgene and Dlb-1 locus in vivo. Mutagenesis, 14: 113-119.
65. Cosentino L & Heddle JA (2000) Differential mutation of transgenic and endogenous loci in vivo. Mutat Res, 454(1-2): 1-10.
66. Cunningham MJ, Choy WN, Arce GT, Rickard LB, Vlachos DA, Kinney LA & Sarrif AM (1986) In vivo sister chromatid exchange and micronucleus induction studies with 1,3-butadiene in B6C3F1 mice and Sprague-Dawley rats. Mutagenesis, 1: 449-452.
67. Cunningham ML, Hayward JJ, Shane BS & Tindall KR (1996) Distinction of mutagenic carcinogens from a mutagenic noncarcinogen in the Big Blue® transgenic mouse. Environ Health Perspect, 104: 683-686.
68. da Costa GG, Manjanatha MG, Marques MM & Beland FA (2002) Induction of lacI mutations in Big Blue® rats treated with tamoxifen and α-hydroxytamoxifen. Cancer Lett, 176(1): 37-45.
69. Davies R, Oreffo VIC, Martin EA, Festing MFW, White INH, Smith LL & Styles JA (1997) Tamoxifen causes gene mutations in the livers of lambda/lacI transgenic rats. Cancer Res, 57: 1288-1293.
70. Davies R, Gant TW, Smith LL & Styles JA (1999) Tamoxifen induces G:C→T:A mutations in the cII gene in the liver of λ/lacI transgenic rats but not at 5′-CpG-3′ dinucleotide sequences as found in the lacI transgene. Carcinogenesis, 20: 1351-1356.
71. Davis CD, Dacquel EJ, Schut HAJ, Thorgeirsson SS & Snyderwine EG (1996) In vivo mutagenicity and DNA adduct levels of heterocyclic amines in Muta™Mice and c-myc/lacZ double transgenic mice. Mutat Res, 356: 287-296.
72. - phage. Mutagenesis, 9: 183-185.
73. Dean SW, Brooks TM, Burlinson B, Mirsalis J, Myhr B, Recio L & Thybaud V (1999) Transgenic mouse mutation assay systems can play an important role in regulatory mutagenicity testing in vivo for the detection of site-of-contact mutagens. Mutagenesis, 14(1): 141-151.
74. de Boer JG & Glickman BW (1998) The lacI gene as a target for mutation in transgenic rodents and Escherichia coli. Genetics, 148: 1441-1451.
75. de Boer JG, Mirsalis JC, Provost GS, Tindall KR & Glickman BW (1996) Spectrum of mutations in kidney, stomach, and liver from lacI transgenic mice recovered after treatment with tris(2,3-dibromopropyl)phosphate. Environ Mol Mutagen, 28: 418-423.
76. de Boer JG, Provost S, Gorelick N, Tindal K & Glickman BW (1998) Spontaneous mutation in lacI transgenic mice: a comparison of tissues. Mutagenesis, 13: 109-114.
77. DECOS (1989) Health-based recommended occupational exposure limits for ethyl methanesulphonate (EMS) methyl methanesulphonate (MMS). Voorburg, Directorate-General of Labour, Dutch Expert Committee for Occupational Standards, pp 1-73 (RA 4/89).
78. Delongchamp RR, Malling HV, Chen JB & Heflich RH (1999) An estimator of the mutant frequency in assays using transgenic animals. Mutat Res, 440: 101-108.
79. Delongchamp RR, Valentine CR & Malling HV (2001) Estimation of the average burst size of ΦX174 am3, cs70 for use in mutation assays with transgenic mice. Environ Mol Mutagen, 37: 356-360.
80. De Silva IU, McHugh PJ, Clingen PH & Hartley JA (2000) Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. Mol Cell Biol, 20(21): 7980-7990.
81. Dobrovolsky VN, Casciano DA & Heflich RH (1999) Tk+/- mouse model for detecting in vivo mutation in an endogenous, autosomal gene. Mutat Res, 423: 125-136.
82. Dobrovolsky VN, Shaddock JG & Heflich RH (2005) Analysis of in vivo mutation in the Hprt and Tk genes of mouse lymphocytes. In: Keohavong P & Grant SG eds. Methods in molecular biology. Vol. 291. Molecular toxicology protocols. Totowa, New Jersey, Humana Press Inc., pp 133-144.
83. Dollé ME & Vijg J (2002) Genome dynamics in aging mice. Genome Res, 12: 1732-1738.
84. Dollé ME, Martus HJ, Gossen JA, Boerrigter ME & Vijg J (1996) Evaluation of a plasmid-based transgenic mouse model for detecting in vivo mutations. Mutagenesis, 11: 111-118.
85. Dollé ME, Giese H, Hopkins CL, Martus HJ, Hausdorff JM & Vijg J (1997) Rapid accumulation of genome rearrangements in liver but not in brain of old mice. Nat Genet, 17: 431-434.
86. Dollé ME, Snyder WK, Gossen JA, Lohman PHM & Vijg J (2000) Distinct spectra of somatic mutations accumulated with age in mouse heart and small intestine. Proc Natl Acad Sci USA, 97: 8403-8408.
87. Dollé ME, Snyder WK, Dunson DB & Vijg J (2002) Mutational fingerprints of aging. Nucleic Acids Res, 30: 545-549.
88. Douglas GR, Gingerich JD, Gossen JA & Bartlett SA (1994) Sequence spectra of spontaneous lacZ gene mutations in transgenic mouse somatic and germline tissues. Mutagenesis, 9: 451-458.
89. Douglas GR, Jiao J, Gingerich JD, Gossen JA & Soper LM (1995a) Temporal and molecular characteristics of mutations induced by ethylnitrosourea in germ cells isolated from seminiferous tubules and in spermatozoa of lacZ transgenic mice. Proc Natl Acad Sci USA, 92: 7485-7489.
90. Douglas GR, Gingerich JD & Soper LM (1995b) Evidence for in vivo non-mutagenicity of the carcinogen hydrazine sulfate in target tissues of lacZ transgenic mice. Carcinogenesis, 16(4): 801-804.
91. Douglas GR, Jiao J, Gingerich JD, Soper LM & Gossen JA (1996) Temporal and molecular characteristics of lacZ mutations in somatic tissues of transgenic mice. Environ Mol Mutagen, 28: 317-324.
92. Douglas GR, Gingerich JD, Soper LM, Potvin M & Bjarnason S (1999) Evidence for the lack of base-change and small-deletion mutation induction by trichloroethylene in lacZ transgenic mice. Environ Mol Mutagen, 34: 190-194.
93. Dybdahl M, Risom L, Bornholdt J, Autrup H, Loft S & Wallin H (2004) Inflammatory and genotoxic effects of diesel particles in vitro and in vivo. Mutat Res, 562(1-2): 119-131.
94. Dycaico MJ, Provost GS, Kretz PL, Ransom SL, Moores JC & Short JM (1994) The use of shuttle vectors for mutation analysis in transgenic mice and rats. Mutat Res, 307(2): 461-478.
95. Dycaico MJ, Stuart GR, Tobal GM, de Boer JG, Glickman BW & Provost GS (1996) Species-specific differences in hepatic mutant frequency and mutational spectrum among λ/lacI transgenic rats and mice following exposure to aflatoxin B1. Carcinogenesis, 17: 2347-2356.
96. Eckhardt K, King M-T, Gocke E & Wild D (1980) Mutagenicity study of Remsen-Fahlberg saccharin and contaminants. Toxicol Lett, 7(1): 51-60.
97. Engle SJ, Stockelman MG, Chen J, Boivin G, Yum MN, Davies PM, Ying MY, Sahota A, Simmonds HA, Stambrook P & Tischfield JA (1996) Adenine phosphoribosyltransferase-deficient mice develop 2,8-dihydroxyadenine nephrolithiasis. Proc Natl Acad Sci USA, 93: 5307-5312.
98. Erexson GL, Watson DE & Tindall KR (1999) Characterization of new transgenic Big Blue® mouse and rat primary fibroblast cell strains for use in molecular toxicology studies. Environ Mol Mutagen, 34: 90-96.
99. European Chemicals Bureau (2002) European Union risk assessment report: o-Anisidine. Luxembourg, European Chemicals Bureau, Institute for Health and Consumer Protection, Office for Official Publications of the European Communities, pp 1-94.
100. Fahrig R (1977) The mammalian spot test (Fellfleckentest) with mice. Arch Toxicol, 38: 87-98.
101. Fahrig R (1988) Positive response of 2-acetylaminofluorene, negative response of 4-acetylaminofluorene in the mammalian spot test. In: Ashby J ed. Evaluation of short-term tests for carcinogens: report of the International Programme on Chemical Safety's collaborative study on in vivo assays. Cambridge, Cambridge University Press, pp 159-163.
102. Fahrig R (1993) Genetic effects of dioxins in the spot test with mice. Environ Health Perspect, 101(Suppl. 3): 257-261.
103. Fahrig R & Steinkamp-Zucht A (1996) Co-recombinogenic and anti-mutagenic effects of diethylhexylphthalate, inactiveness of pentachlorophenol in the spot test with mice. Mutat Res, 354: 59-67.
104. Farabaugh PJ (1978) Sequence of the lacI gene. Nature, 274(5673): 765-769.
105. Fletcher K, Tinwell H & Ashby J (1998) Mutagenicity of the human bladder carcinogen 4-aminobiphenyl to the bladder of Muta™Mouse transgenic mice. Mutat Res, 400: 245-250.
106. Fletcher K, Soames AR, Tinwell H, Lefevre PA & Ashby J (1999) Hepatic gene mutations induced in Big Blue® rats by both the potent rat liver azo-carcinogen 6BT and its reported noncarcinogenic analogue 5BT. Environ Mol Mutagen, 34: 148-153.
107. Friedberg EC, Walker GC & Siede W ed (1995) DNA repair and mutagenesis. Washington, DC, ASM Press, pp 1-698.
108. Furuno-Fukushi I, Masumura K, Furuse T, Noda Y, Takahagi M, Saito T, Hoki Y, Suzuki H, Wynshaw-Boris A, Nohmi T & Tatsumi K (2003) Effect of Atm disruption on spontaneously arising and radiation-induced deletion mutations in mouse liver. Radiat Res, 160: 549-558.
109. GENE-TOX (1992) N-Propyl-N-nitrosourea. CAS: 816-57-9. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Genetic Toxicology (Mutagenicity) (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?GENETOX).
110. GENE-TOX (1995a) Beta-Propiolactone. CAS: 57-57-8. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Genetic Toxicology (Mutagenicity) (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?GENETOX).
111. GENE-TOX (1995b) Dimethylnitrosamine. CAS: 62-75-9. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Genetic Toxicology (Mutagenicity) (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?GENETOX).
112. GENE-TOX (1995c) Ethyl methanesulfonate. CAS: 62-50-0. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Genetic Toxicology (Mutagenicity) (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?GENETOX).
113. GENE-TOX (1995d) Quinoline. CAS: 91-22-5. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Genetic Toxicology (Mutagenicity) (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?GENETOX).
114. GENE-TOX (1998a) 1-Ethyl-1-nitrosourea. CAS: 759-73-9. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Genetic Toxicology (Mutagenicity) (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?GENETOX).
115. GENE-TOX (1998b) 1-Methyl-1-nitrosourea. CAS: 684-93-5. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Genetic Toxicology (Mutagenicity) (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?GENETOX).
116. GENE-TOX (1998c) 4-Acetylaminofluorene. CAS: 28322-02-3. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Genetic Toxicology (Mutagenicity) (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?GENETOX).
117. GENE-TOX (1998d) 4-Amino-1,1′-biphenyl. CAS: 92-67-1. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Genetic Toxicology (Mutagenicity) (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?GENETOX).
118. GENE-TOX (1998e) 4-Nitroquinoline 1-oxide. CAS: 56-57-5. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Genetic Toxicology (Mutagenicity) (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?GENETOX).
119. GENE-TOX (1998f) 7,12-Dimethylbenz[a]anthracene. CAS: 57-97-6. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Genetic Toxicology (Mutagenicity) (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?GENETOX).
120. GENE-TOX (1998g) Chlorambucil. CAS: 305-03-3. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Genetic Toxicology (Mutagenicity) (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?GENETOX).
121. GENE-TOX (1998h) Diethylnitrosamine. CAS: 55-18-5. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Genetic Toxicology (Mutagenicity) (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?GENETOX).
122. GENE-TOX (1998i) Mitomycin C. CAS: 50-07-7. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Genetic Toxicology (Mutagenicity) (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?GENETOX).
123. GENE-TOX (1998j) N,N-Dipropylnitrosamine. CAS: 621-64-7. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Genetic Toxicology (Mutagenicity) (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?GENETOX).
124. GENE-TOX (1998k) Tris(2,3-Dibromopropyl)phosphate. CAS: 126-72-7. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Genetic Toxicology (Mutagenicity) (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?GENETOX).
125. GENE-TOX (1998l) Urethane. CAS: 51-79-6. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Genetic Toxicology (Mutagenicity) (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?GENETOX).
126. Gilbert W & Müller-Hill B (1967) The lac operator is DNA. Proc Natl Acad Sci USA, 58: 2415-2421.
127. Glazer PM, Sarkar SN & Summers WC (1986) Detection and analysis of UV-induced mutations in mammalian cell DNA using a lambda phage shuttle vector. Proc Natl Acad Sci USA, 83: 1041-1044.
128. Gocke E, Wild D, Eckhardt K & King MT (1983) Mutagenicity studies with the mouse spot test. Mutat Res, 117: 201-212.
129. Gollapudi BB, Jackson KM & Stott WT (1998) Hepatic lacI and cII mutation in transgenic (ALIZ) rats treated with dimethylnitrosamine. Mutat Res, 419: 131-135.
130. Gondo Y, Shioyama Y, Nakao K & Katsuki M (1996) A novel positive detection system of in vivo mutations in rpsL (strA) transgenic mice. Mutat Res, 360: 1-14.
131. Gordon JW & Ruddle FH (1983) Gene transfer into mouse embryos: production of transgenic mice by pronuclear injection. Meth Enzymol, 101: 411-433.
132. Gordon JW, Scangos GA, Plotkin DJ, Barbosa JA & Ruddle FH (1980) Genetic transformation of mouse embryos by microinjection of purified DNA. Proc Natl Acad Sci USA, 77(12): 7380-7384.
133. Gorelick N (1995) Overview of mutation assays in transgenic mice for routine testing. Environ MoI Mutagen, 25: 218-230.
134. Gorelick NJ & Thompson ED (1994) Overview of the workshops on statistical analysis of mutation data from transgenic mice. Environ Mol Mutagen, 23: 12-16.
135. Gorelick NJ, Andrews JL, Gu M & Glickman BW (1995) Mutational spectra in the lacI gene in skin from 7,12-dimethylbenz[a]anthracene- treated and untreated transgenic mice. Mol Carcinog, 14: 53-62.
136. Gorelick NJ, Andrews JL, Gibson DP, Carr GJ & Aardema MJ (1997) Evaluation of lacI mutation in germ cells and micronuclei in peripheral blood after treatment of male lacI transgenic mice with ethylnitrosourea, isopropylmethane sulfonate or methylmethane sulfonate. Mutat Res, 388: 187-195.
137. Gorelick NJ, Andrews JL, de Boer JG, Young R, Gibson DP & Walker VE (1999) Tissue-specific mutant frequencies and mutational spectra in cyclophosphamide-treated lacI transgenic mice. Environ Mol Mutagen, 34: 154-166.
138. Gossen J & Vijg J (1993) Transgenic mice as model systems for studying gene mutations in vivo. Trends Genet, 9: 27-31.
139. Gossen JA, De Leeuw WJF, Tan CHT, Zwarthoff EC, Berends F, Lohman PHM, Knook DL & Vijg J (1989) Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. Proc Natl Acad Sci USA, 86: 7971-7975.
140. - plasmids. Nucleic Acids Res, 20: 3254.
141. Gossen JA, de Leeuw WJF, Molijn AC & Vijg J (1993) Plasmid rescue from transgenic mouse DNA using LacI repressor protein conjugated to magnetic beads. BioTechniques, 14(4): 624-629.
142. Gossen JA, Martus H-J, Wei JY & Vijg J (1995) Spontaneous and X-ray-induced deletion mutations in a LacZ plasmid-based transgenic mouse model. Mutat Res, 331: 89-97.
143. Gunz D, Shephard SE & Lutz WK (1993) Can nongenotoxic carcinogens be detected with the lacI transgenic mouse mutation assay? Environ Mol Mutagen, 21: 209-211.
144. Hachiya N & Motohashi Y (2000) Examination of lacZ mutant induction in the liver and testis of Muta Mouse following injection of halogenated aliphatic hydrocarbons classified as human carcinogens. Ind Health, 38(2): 213-220.
145. Hachiya N, Yajima N, Hatakeyama S, Yuno K, Okada N, Umeda Y, Wakata A & Motohashi Y (1999) Induction of lacZ mutation by 7,12-dimethylbenz[a]anthracene in various tissues of transgenic mice. Mutat Res, 444: 283-295.
146. Hakura A, Tsutsui Y, Sonoda J, Kai J, Imade T, Shimada M, Sugihara Y & Mikami T (1998) Comparison between in vivo mutagenicity and carcinogenicity in multiple organs by benzo[a]pyrene in the lacZ transgenic mouse (Muta™Mouse). Mutat Res, 398: 123-130.
147. Hakura A, Tsutsui Y, Sonoda J, Mikami T, Tsukidate K, Sagami F & Kerns WD (1999) Multiple organ mutation in the lacZ transgenic mouse (Muta™Mouse) 6 months after oral treatment (5 days) with benzo[a]pyrene. Mutat Res, 426(1): 71-77.
148. Hakura A, Tsutsui Y, Sonoda J, Tsukidate K, Mikami T & Sagami F (2000) Comparison of the mutational spectra of the lacZ transgene in four organs of the Muta™Mouse treated with benzo[a]pyrene: target organ specificity. Mutat Res, 447(2): 239-247.
149. Halangoda A, Still JG, Hill KA & Sommer SS (2001) Spontaneous microdeletions and microinsertions in a transgenic mouse mutation detection system: analysis of age, tissue, and sequence specificity. Environ Mol Mutagen, 37: 311-323.
150. Hamoud MA, Ong T, Petersen M & Nath J (1989) Effects of quinoline and 8-hydroxyquinoline on mouse bone marrow erythrocytes as measured by the micronucleus assay. Teratog Carcinog Mutagen, 9: 111-118.
151. Hansen M, Hald MT, Autrup H, Vogel U, Bornholdt J, Moller P, Molck AM, Lindecrona R, Poulsen HE, Wallin H, Loft S & Dragsted LO (2004) Sucrose and IQ induced mutations in rat colon by independent mechanism. Mutat Res, 554(1-2): 279-286.
152. Hara T, Hirano K, Hirano N, Tamura H, Sui H, Shibuya T, Hyogo A, Hirashio T, Tokai H, Yamashita Y & Kura K (1999) Mutation induction by N-propyl-N-nitrosourea in eight Muta™Mouse organs. Mutat Res, 444: 297-307.
153. Harbach PR, Zimmer DM, Filipunas AL, Mattes WB & Aaron CS (1999) Spontaneous mutation spectrum at the lambda cII locus in liver, lung, and spleen tissue of Big Blue® transgenic mice. Environ Mol Mutagen, 33(2): 132-143.
154. Hart J (1985) The mouse spot test: results with a new cross. Arch Toxicol, 58(1): 1-4.
155. Hashimoto K, Ohshawa K & Kimura M (2004) Mutations induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in the lacZ and cII genes of Muta™Mouse. Mutat Res, 560(2): 119-131.
156. - selection. Environ Mol Mutagen, 41: 253-259.
157. Hayward JJ, Shane BS, Tindall KR & Cunningham ML (1995) Differential in vivo mutagenicity of the carcinogen/noncarcinogen pair 2,4- and 2,6-diaminotoluene. Carcinogenesis, 16(10): 2429-2433.
158. Health Canada (2004) Detailed review of transgenic rodent mutation assays (draft). Ottawa, Ontario, Health Canada, pp 1-584.
159. Heddle JA (1999) Mutant manifestation: the time factor in somatic mutagenesis. Mutagenesis, 14: 1-3.
160. Heddle JA, Hite M, Kirkhart B, Mavournin K, MacGregor JT, Newell GW & Salamone MF (1983) The induction of micronuclei as a measure of genotoxicity: A report of the U.S. Environmental Protection Agency GENE-TOX Program. Mutat Res, 123(1): 61-118.
161. Heddle JA, Dean S, Nohmi T, Boerrigter M, Casciano D, Douglas GR, Glickman BW, Gorelick NJ, Mirsalis JC, Martus H-J, Skopek TR, Thybaud V, Tindall KR & Yajima N (2000) In vivo transgenic mutation assays. Environ Mol Mutagen, 35: 253-259.
162. Heddle JA, Martus HJ & Douglas GR (2003) Treatment and sampling protocols for transgenic mutation assays. Environ Mol Mutagen, 41(1): 1-6.
163. Hill KA, Wang J, Farwell KD & Sommer SS (2003) Spontaneous tandem-base mutations (TBM) show dramatic tissue, age, pattern and spectrum specificity. Mutat Res, 534: 173-183.
164. Hill KA, Buettner VL, Halangoda A, Kunishige M, Moore SR, Scaringe WA & Sommer SS (2004) Spontaneous mutation in Big Blue® mice from fetus to old age: Tissue-specific time courses of mutation frequency but similar mutation types. Environ Mol Mutagen, 43(2): 110-120.
165. Hoogervorst EM, van Oostrom CT, Beems RB, van Benthem J, Gielis S, Vermeulen JP, Wester PW, Vos JG, de Vries A & van Steeg H (2004) p53 heterozygosity results in an increased 2-acetylaminofluorene-induced urinary bladder but not liver tumor response in DNA repair-deficient Xpa mice. Cancer Res, 64: 5118-5126.
166. Hooker AM, Horne R, Morley AA & Sykes PJ (2002) Dose-dependent increase or decrease of somatic intrachromosomal recombination produced by etoposide. Mutat Res, 500: 117-124.
167. Hooker AM, Bhat M, Day TK, Lane JM, Swinburne SJ, Morley AA & Sykes PJ (2004a) The linear no-threshold model does not hold for low dose ionizing radiation. Radiat Res, 162: 447-452.
168. Hooker AM, Morley AA, Tilley WD & Sykes PJ (2004b) Cancer-associated genes can affect somatic intrachromosomal recombination early in carcinogenesis. Mutat Res, 550: 1-10.
169. Hoorn AJW, Custer LL, Myhr BC, Brusick D, Gossen J & Vijg J (1993) Detection of chemical mutagens using Muta™Mouse: a transgenic mouse model. Mutagenesis, 8: 7-10.
170. Horiguchi M, Masumura K, Ikehata H, Ono T, Kanke Y, Sofuni T & Nohmi T (1999) UVB-induced gpt mutations in the skin of gpt delta transgenic mice. Environ Mol Mutagen, 34: 72-79.
171. Horiguchi M, Masumura K, Ikehata H, Ono T, Kanke Y & Nohmi T (2001) Molecular nature of ultraviolet B light-induced deletions in the murine epidermis. Cancer Res, 61: 3913-3918.
172. Horsfall MJ & Glickman BW (1989) Mutational specificities of environmental carcinogens in the lacI gene of Escherichia coli. I. The direct-acting analogue N-nitroso-N-methyl-N-alpha- acetoxymethylamine. Carcinogenesis, 10(5): 817-822.
173. Hoshi M, Morimura K, Wanibuchi H, Wei M, Okochi E, Ushijima T, Takaoka K & Fukushima S (2004) No-observed effect levels for carcinogenicity and for in vivo mutagenicity of a genotoxic carcinogen. Toxicol Sci, 81(2): 273-279.
174. Hoyes KP, Wadeson PJ, Sharma HL, Hendry JH & Morris ID (1998) Mutation studies in lacI transgenic mice after exposure to radiation or cyclophosphamide. Mutagenesis, 13: 607-612.
175. HSDB (2003a) 2-Acetylaminofluorene. CAS: 53-96-3. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Hazardous Substances Data Bank (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB).
176. HSDB (2003b) Quinoline. CAS: 91-22-5. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Hazardous Substances Data Bank.
177. Hüttner E, Braun R & Schöneich J (1988) Mammalian spot test with the mouse for detection of transplacental genetic effects induced by 2-acetylaminofluorene and 4-acetylaminofluorene. In: Ashby J ed. Evaluation of short-term tests for carcinogens: report of the International Programme on Chemical Safety's collaborative study on in vivo assays. Cambridge, Cambridge University Press, pp 164-167.
178. IARC (1971) 4-Aminobiphenyl. In: Some inorganic substances, chlorinated hydrocarbons, aromatic amines, N-nitroso compounds, and natural products. Lyon, International Agency for Research on Cancer, pp 74-79 (IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man, Vol. 1).
179. IARC (1974a) Ethyl methanesulfonate. In: Some anti-thyroid and related substances, nitrofurans and industrial chemicals. Lyon, International Agency for Research on Cancer, pp 245-251 (IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man, Vol. 7).
180. IARC (1974b) Methyl methanesulfonate. In: Some anti-thyroid and related substances, nitrofurans and industrial chemicals. Lyon, International Agency for Research on Cancer, pp 253-260 (IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man, Vol. 7).
181. IARC (1974c) N-Methyl-N′-nitro-N- nitrosoguanidine. In: Some aromatic amines, hydrazine and related substances, N-nitroso compounds and miscellaneous alkylating agents. Lyon, International Agency for Research on Cancer, pp 183-195 (IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man, Vol. 4).
182. IARC (1974d) Urethane. In: Some anti-thyroid and related substances, nitrofurans and industrial chemicals. Lyon, International Agency for Research on Cancer, pp 111-140 (IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man, Vol. 7).
183. IARC (1976) Mitomycin C. In: Some naturally occurring substances. Lyon, International Agency for Research on Cancer, pp 171-179 (IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man, Vol. 10).
184. IARC (1977a) Asbestos. Lyon, International Agency for Research on Cancer, pp 1-106 (IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man, Vol. 14).
185. IARC (1977b) Phenobarbital and phenobarbital sodium. In: Some miscellaneous pharmaceutical substances. Lyon, International Agency for Research on Cancer, pp 157-181 (IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man, Vol. 13).
186. IARC (1978a) N-Nitrosodiethylamine. In: Some N-nitroso compounds. Lyon, International Agency for Research on Cancer, pp 89-106 (IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 17).
187. IARC (1978b) N-Nitrosodimethylamine. In: Some N-nitroso compounds. Lyon, International Agency for Research on Cancer, pp 125-175 (IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 17).
188. IARC (1978c) N-Nitroso-N-ethylurea. In: Some N-nitroso compounds. Lyon, International Agency for Research on Cancer, pp 191-215 (IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 17).
189. IARC (1978d) N-Nitroso-N-methylurea. In: Some N-nitroso compounds. Lyon, International Agency for Research on Cancer, pp 227-255 (IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 17).
190. IARC (1979) 1,2-Dichloroethane. In: Some halogenated hydrocarbons. Lyon, International Agency for Research on Cancer, pp 429-448 (IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 20).
191. IARC (1980) Saccharin. In: Some non-nutritive sweetening agents. Lyon, International Agency for Research on Cancer, pp 132-170 (IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 22).
192. IARC (1981a) Chlorambucil. In: Some antineoplastic and immunosuppressive agents. Lyon, International Agency for Research on Cancer, pp 115-136 (IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 26).
193. IARC (1981b) Cyclophosphamide. In: Some antineoplastic and immunosuppressive agents. Lyon, International Agency for Research on Cancer, pp 165-202 (IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 26).
194. IARC (1981c) Procarbazine hydrochloride. In: Some antineoplastic and immunosuppressive agents. Lyon, International Agency for Research on Cancer, pp 311-339 (IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 26).
195. IARC (1982) Benzene. In: Some industrial chemicals and dyestuffs. Lyon, International Agency for Research on Cancer, pp 94-148 (IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 29).
196. IARC (1983) Agaritine (L-glutamic acid-5-[2-(4-hydroxymethyl)- phenylhydrazide]). In: Some food additives, feed additives and naturally occurring substances. Lyon, International Agency for Research on Cancer, pp 63-69 (IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 31).
197. IARC (1985) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). In: Tobacco habits other than smoking. Lyon, International Agency for Research on Cancer, pp 209-223 (IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 37).
198. IARC (1987a) 4,4′-Methylene bis(2-methylaniline) (Group 2B). In: Overall evaluations of carcinogenicity: an updating of IARC Monographs Volumes 1 to 42. Lyon, International Agency for Research on Cancer, pp 248-250 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Suppl. 7).
199. IARC (1987b) Asbestos (Group 1). In: Overall evaluations of carcinogenicity: an updating of IARC Monographs Volumes 1 to 42. Lyon, International Agency, for Research on Cancer, pp 106-116 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Suppl. 7).
200. IARC (1987c) Asbestos. In: Genetic and related effects: an updating of selected IARC monographs from volumes 1 to 42. Lyon, International Agency for Research on Cancer, pp 77-80 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Suppl. 6).
201. IARC (1987d) Chlorambucil (Group 1). In: Overall evaluations of carcinogenicity: an updating of IARC Monographs Volumes 1 to 42. Lyon, International Agency for Research on Cancer, pp 144-145 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Suppl. 7).
202. IARC (1987e) Cyclophosphamide (Group 1). In: Overall evaluations of carcinogenicity: An updating of IARC Monographs Volumes 1 to 42. Lyon, International Agency for Research on Cancer, pp 182-184 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Suppl. 7).
203. IARC (1987f) N-Methyl-N′-nitro-N- nitrosoguanidine. In: Genetic and related effects: an updating of selected IARC monographs from volumes 1 to 42. Lyon, International Agency for Research on Cancer, 394-398 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Suppl. 6).
204. IARC (1987g) Phenobarbital (Group 2b). In: Overall evaluations of carcinogenicity: an updating of IARC Monographs Volumes 1 to 42. Lyon, International Agency for Research on Cancer, pp 313-316 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Suppl. 7).
205. IARC (1987h) Phenobarbital. In: Genetic and related effects: an updating of selected IARC monographs from volumes 1 to 42. Lyon, International Agency for Research on Cancer, pp 455-458 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Suppl. 6).
206. IARC (1987i) Procarbazine hydrochloride (Group 2A). In: Overall evaluations of carcinogenicity: an updating of IARC Monographs Volumes 1 to 42. Lyon, International Agency for Research on Cancer, pp 327-328 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Suppl. 7).
207. IARC (1987j) Saccharin (Group B). In: Overall evaluations of carcinogenicity: an updating of IARC Monographs Volumes 1 to 42. Lyon, International Agency for Research on Cancer, pp 334-339 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Suppl. 7).
208. IARC (1993a) Aflatoxins. In: Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. Lyon, International Agency for Research on Cancer, pp 245-395 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 56).
209. IARC (1993b) IQ (2-Amino-3-methylimidazo[4,5-f]quinoline). In: Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. Lyon, International Agency for Research on Cancer, pp 165-195 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 56).
210. IARC (1993c) MeIQ (2-Amino-3,4-dimethylinidazo[4,5-f]quinoline). In: Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. Lyon, International Agency for Research on Cancer, pp 197-210 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 56).
211. IARC (1993d) PhIP (2-Amino-1-methyl-6-phenylimidazo[4,5-b] pyridine). In: Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. Lyon, International Agency for Research on Cancer, pp 229-242 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 56).
212. IARC (1993e) MeIQx (2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline) . In: Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. Lyon, International Agency for Research on Cancer, pp 211-228 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 56).
213. IARC (1994a) Acrylamide. In: Some industrial chemicals. Lyon, International Agency for Research on Cancer, pp 389-433 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 60).
214. IARC (1994b) Ethylene oxide. In: Some industrial chemicals. Lyon, International Agency for Research on Cancer, pp 73-160 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 60).
215. IARC (1996) Tamoxifen. In: Some pharmaceutical drugs. Lyon, International Agency for Research on Cancer, pp 253-365 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 66).
216. IARC (1997) Polychlorinated dibenzo-para-dioxins. In: Polychlorinated dibenzo-paradioxins and polychlorinated dibenzofurans. Lyon, International Agency for Research on Cancer, pp 194-219 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 69).
217. IARC (1999a) 1,3-Butadiene. In: Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide (part one). Lyon, International Agency for Research on Cancer, pp 109-225 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 71).
218. IARC (1999b) Methyl methanesulfonate. In: Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide (part three A). Lyon, International Agency for Research on Cancer, pp 1059-1078 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 71).
219. IARC (1999c) Saccharin and its salts. In: Some chemicals that cause tumours of the kidney or urinary bladder in rodents and some other substances. Lyon, International Agency for Research on Cancer, pp 517-624 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 73).
220. IARC (1999d) Ethylene dibromide. In: Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide (part two). Lyon, International Agency for Research on Cancer, p 641 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 71).
221. IARC (1999e) 1,2-Dibromo-3-chloropropane. In: Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide (part two). Lyon, International Agency for Research on Cancer, p 479 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 71).
222. IARC (1999f) 1,2-Dichloroethane. In: Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide (part two). Lyon, International Agency for Research on Cancer, pp 501-529 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 71).
223. IARC (2001) Chlordane and heptachlor. In: Some thyrotropic agents. Lyon, International Agency for Research on Cancer, pp 411-493 (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 79).
224. Ikeda H, Shimizu T, Ukita T & Kumagai M (1995) A novel assay for illegitimate recombination in Escherichia coli: simulation of lambda bio transducing phage formation by ultra-violet light and its independence from RecA function. Adv Biophys, 31:197-208.
225. IPCS (1993) Benzene. Geneva, Wortd Health Organization, International Programme on Chemical Safety, pp 1-156 (Environmental Health Criteria 150).
226. IPCS (1995a) Methyl bromide. Geneva, World Health Organization, International Programme on Chemical Safety, pp 1-324 (Environmental Health Criteria 166).
227. IPCS (1995b) Tris(2,3-dibromopropyl) phosphate and bis(2,3-dibromopropyl) phosphate. Geneva, World Health Organization, International Programme on Chemical Safety, pp 1-129 (Environmental Health Criteria 173).
228. IPCS (1998a) Limonene. Geneva, World Health Organization, International Programme on Chemical Safety, pp 1-32 (Concise International Chemical Assessment Document No. 5).
229. IPCS (1998b) Selected non-heterocyclic polycyclic aromatic hydrocarbons. Geneva, World Health Organization, International Programme on Chemical Safety, pp 1-883 (Environmental Health Criteria 202).
230. IRIS (2002a) Bromomethane. CAS: 74-83-9. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Integrated Risk Information System (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?IRIS).
231. IRIS (2002b) N-Nitrosodi-n-propylamine. CAS: 621-64-7. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Integrated Risk Information System (http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?IRIS).
232. IRIS (2002c) Quinoline. CAS: 91-22-5. Bethesda, Maryland, United States Department of Health and Human Services, National Institutes of Health, National Library of Medicine, Integrated Risk Information System (http://toxnet.nlm.nih. gov/cgi-bin/sis/htmlgen?IRIS).
233. Ishidate M & Odashima S (1977) Chromosome tests with 134 compounds on Chinese hamster cells in vitro - a screening for chemical carcinogens. Mutat Res, 48(3-4): 337-354.
234. Itoh S, Miura M & Shimada H (1997) Germ cell mutagenesis in lacZ transgenic mice treated with methyl methanesulfonate. Mutat Res, 388: 223-228.
235. Itoh S, Miura M, Itoh T, Miyauchi Y, Suga M, Takahashi Y, Kasahara Y, Yamamura E, Hirono H & Shimada H (1999) N-Nitrosodi-n- propylamine induces organ specific mutagenesis with specific expression times in lacZ transgenic mice. Mutat Res, 444: 309-319.
236. Itoh T, Suzuki T, Nishikawa A, Furukawa F, Takahashi M, Xue W, Sofuni T & Hayashi M (2000) In vivo genotoxicity of 2-amino-3,8-dimethylimidazo[4,5- f]quinoline in lacI transgenic (Big Blue®) mice. Mutat Res, 468: 19-25.
237. Itoh T, Kuwahara T, Suzuki T, Hayashi M & Ohnishi Y (2003) Regional mutagenicity of heterocyclic amines in the intestine: mutation analysis of the cII gene in lambda/lacZ transgenic mice. Mutat Res, 539(1-2): 99-108.
238. Jakubczak JL, Merlino G, French JE, Muller WJ, Paul B, Adhya S & Garges S (1996) Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage λ transgene target. Proc Natl Acad Sci USA, 93: 9073-9078.
239. JEMS/MMS (1996) Organ variation in the mutagenicity of ethylnitrosourea in Muta™Mouse: results of the collaborative study on the transgenic mutation assay by JEMS/MMS. Environ Mol Mutagen, 28: 363-375.
240. Jenssen D & Ramel C (1976) Dose response at low doses of X-irradiation and MMS on the induction of micronuclei in mouse erythroblasts. Mutat Res, 41: 311-319.
241. Jenssen D & Ramel C (1980) The micronucleus test as part of a short-term mutagenicity test program for the prediction of carcinogenicity evaluated by 143 agents tested. Mutat Res, 75: 191-202.
242. Kalnins A, Otto K, Rüther U & Müller-Hill B (1983) Sequence of the lacZ gene of Escherichia coli. EMBO J, 2: 593-597.
243. Katoh M, Horiya N & Valdivia RPA (1997) Mutations induced in male germ cells after treatment of transgenic mice with ethylnitrosourea. Mutat Res, 388: 229-237.
244. Kliesch U, Danford N & Adler I-D (1981) Micronucleus test and bone-marrow chromosome analysis: a comparison of 2 methods in vivo for evaluating chemically induced chromosomal alterations. Mutat Res, 80(2): 321-332.
245. Klungland A, Rosewell I, Hollenbach S, Larsen E, Daly G, Epe B, Seeberg E, Lindahl T & Barnes DE (1999) Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc Natl Acad Sci USA, 96: 13300-13305.
246. Kohara A, Suzuki T, Honma M, Hirano N, Ohsawa K, Ohwada T & Hayashi M (2001) Mutation spectrum of o-aminoazotoluene in the cII gene of lambda/lacZ transgenic mice (Muta™Mouse). Mutat Res, 491(1-2): 211-220.
247. Kohara A, Suzuki T, Honma M, Ohwada T & Hayashi M (2002a) Mutagenicity of aristolochic acid in the λ/lacZ transgenic mouse (Muta™Mouse). Mutat Res, 515(1-2): 63-72.
248. Kohara A, Suzuki T, Honma M, Oomori T, Ohwada T & Hayashi M (2002b) Dinitropyrenes induce gene mutations in multiple organs of the λ/lacZ transgenic mouse (Muta™Mouse). Mutat Res, 515(1-2): 73-83.
249. Kohler SW, Provost GS, Kretz PL, Fieck A, Sorge JA & Short JM (1990) The use of transgenic mice for short-term, in vivo mutagenicity testing. Genet Anal Tech Appl, 7: 212-218.
250. Kohler SW, Provost GS, Fieck A, Kretz PL, Bullock WO, Putman DL, Sorge JA & Short JM (1991a) Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/lacI shuttle vector. Environ Mol Mutagen, 18: 316-321.
251. Kohler SW, Provost GS, Fieck A, Kretz PL, Bullock WO, Sorge JA, Putman DL & Short JM (1991b) Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice. Proc Natl Acad Sci USA, 88: 7958-7962.
252. Kosinska W, von Pressentin MdM & Guttenplan JB (1999) Mutagenesis induced by benzo[a]pyrene in lacZ mouse mammary and oral tissues: comparisons with mutagenesis in other organs and relationships to previous carcinogenicity assays. Carcinogenesis, 20(6): 1103-1106.
253. Krebs O & Favor J (1997) Somatic and germ cell mutagenesis in lambda lacZ transgenic mice treated with acrylamide or ethylnitrosourea. Mutat Res, 388: 239-248.
254. Leach EG, Narayanan L, Havre PA, Gunther EJ, Yeasky TM & Glazer PM (1996a) Tissue specificity of spontaneous point mutations in lambda supF transgenic mice. Environ Mol Mutagen, 28: 459-464.
255. Leach EG, Gunther EJ, Yeasky TM, Gibson LH, Yang-Feng TL & Glazer PM (1996b) Frequent spontaneous deletions at a shuttle vector locus in transgenic mice. Mutagenesis, 11(1): 49-56.
256. Lefevre PA, Tinwell H & Ashby J (1997) Mutagenicity of the potent rat hepatocarcinogen 6BT to the liver of transgenic (lacI) rats: consideration of a reduced mutation assay protocol. Mutagenesis, 12: 45-47.
257. Limoli CL, Giedzinski E, Bonner WM & Cleaver JE (2002) UV-induced replication arrest in the xeroderma pigmentosum variant leads to DNA double-strand breaks, gamma-H2AX formation, and Mre11 relocalization. Proc Natl Acad Sci USA, 99(1): 233-238.
258. Lonardo EC, Perdue PA & Freeman JJ (1996) The detection of gene mutation in transgenic mice (Big Blue®) following administration of a known mutagen 7,12-dimethylbenz[a]anthracene - (DMBA). Abstr Annu Meet Environ Mutagen Soc, 1996: 42.
259. Loprieno N, Boncristiani G & Loprieno G (1991) An experimental approach to identifying the genotoxic risk from cooked meat mutagens. Food Chem Toxicol, 29(6): 377-386.
260. Loveday KS, Anderson BE, Resnick MA & Zeiger E (1990) Chromosome aberration and sister chromatid exchange tests in Chinese hamster ovary cells in vitro. V: Results with 46 chemicals. Environ Mol Mutagen, 16: 272-303.
261. Lynch AM, Gooderham NJ, Davies DS & Boobis AR (1998) Genetic analysis of PHIP intestinal mutations in Muta™Mouse. Mutagenesis, 13(6): 601-605.
262. Machemer L & Lorke D (1978) Mutagenicity studies with praziquantel, a new anthelmintic drug, in mammalian systems. Arch Toxicol, 39: 187-197.
263. MAK (1976) β-Propiolacton. In: Gesundheitsschädliche Arbeitsstoffe: Toxikologisch-arbeitsmedizinische Begründung von MAK-Werten. Vol. 9. Deutsche Forschungsgemeinschaft (DFG). Weinheim, Wiley-VCH, pp 1-8.
264. MAK (1991) N-Nitrosamines. In: Occupational toxicants - critical data evaluation for MAK values and classification of carcinogens. Vol. 1. Deutsche Forschungsgemeinschaft (DFG). Weinheim, Wiley-VCH, pp 261-289.
265. MAK (1994) Toluene-2,4-diamine. In: Occupational toxicants - critical data evaluation for MAK values and classification of carcinogens. Vol. 6. Deutsche Forschungsgemeinschaft (DFG). Weinheim, Wiley-VCH, pp 339-352.
266. MAK (1998) Trichloroethylene. In: Occupational toxicants - critical data evaluation for MAK values and classification of carcinogens. Vol. 10. Deutsche Forschungsgemeinschaft (DFG). Weinheim, Wiley-VCH, pp 221-236.
267. MAK (2000) Chloroform. In: Occupational toxicants - critical data evaluation for MAK values and classification of carcinogens. Vol. 14. Deutsche Forschungsgemeinschaft (DFG). Weinheim, Wiley-VCH, pp 19-58.
268. MAK (2002a) Di(2-ethylhexyl)phthalat (DEHP). In: Gesundheitsschä dliche Arbeitsstoffe: Toxikologisch-arbeitsmedizinische Begründung von MAK-Werten. Vol. 4. Deutsche Forschungsgemeinschaft (DFG). Weinheim, Wiley-VCH, pp 1-81.
269. MAK (2002b) Carbon tetrachloride. In: Occupational toxicants - critical data evaluation for MAK values and classification of carcinogens. Vol. 18. Deutsche Forschungsgemeinschaft (DFG). Weinheim, Wiley-VCH, pp 82-106.
270. Malling HV & Delongchamp RR (2001) Direct separation of in vivo and in vitro am3 revertants in transgenic mice carrying the ΦX174 am3, cs70 vector. Environ Mol Mutagen, 37: 345-355.
271. Malling HV, Delongchamp RR & Valentine CR (2003) Three origins of ΦX174 am3 revertants in transgenic cell culture. Environ Mol Mutagen, 42: 258-273.
272. Manjanatha MG, Shelton SD, Aidoo A, Lyn-Cook LE & Casciano DA (1998) Comparison of in vivo mutagenesis in the endogenous Hprt gene and the lacI transgene of Big Blue® rats treated with 7,12- dimethylbenz[a]anthracene. Mutat Res, 401: 165-178.
273. Manjanatha MG, Shelton SD, Culp SJ, Blankenship LR & Casciano DA (2000) DNA adduct formation and molecular analysis of in vivo lacI mutations in the mammary tissue of Big Blue® rats treated with 7,12-dimethylbenz[a]anthracene. Carcinogenesis, 21(2): 265-273.
274. Marshall E (2001) Genome sequencing. Celera assembles mouse genome; public labs plan new strategy. Science, 292: 822-823.
275. Masumura K, Matsui M, Katoh M, Horiya N, Ueda O, Tanabe H, Yamada M, Suzuki H, Sofuni T & Nohmi T (1999a) Spectra of gpt mutations in ethylnitrosourea-treated and untreated transgenic mice. Environ Mol Mutagen, 34: 1-8.
276. Masumura K, Matsui K, Yamada M, Horiguchi M, Ishida K, Watanabe M, Ueda O, Suzuki H, Kanke Y, Tindall KR, Wakabayashi K, Sofuni T & Nohmi T (1999b) Mutagenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b)]pyridine (PhIP) in the new gpt δ-transgenic mouse. Cancer Lett, 143: 241-244.
277. Masumura K, Matsui K, Yamada M, Horiguchi M, Ishida K, Watanabe M, Wakabayashi K & Nohmi T (2000) Characterization of mutations induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b)]pyridine in the colon of gpt delta transgenic mouse: novel G:C deletions beside runs of identical bases. Carcinogenesis, 21(11): 2049-2056.
278. Masumura K, Kuniya K, Kurobe T, Fukuoka M, Yatagai F & Nohmi T (2002) Heavy-ion-induced mutations in the gpt delta transgenic mouse: Comparison of mutation spectra induced by heavy-ion, X-ray, and γ-ray radiation. Environ Mol Mutagen, 40(3): 207-215.
279. Matsuoka A, Hayashi M & Ishidate M (1979) Chromosomal aberration tests on 29 chemicals combined with S9 mix in vitro. Mutat Res, 66(3): 277-290.
280. Matsuoka F, Nagawa F, Okazaki K, Kingsbury L, Yoshida K, Muller U, Larue DT, Winter JA & Sakano H (1991) Detection of somatic DNA recombination in the transgenic mouse brain. Science, 254: 81-66.
281. Mavoumin KH, Blakey DH, Cimino MC, Salamone MF & Heddle JA (1990) The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the U.S. Environmental Protection Agency GENE-TOX Program. Mutat Res, 239: 29-80.
282. Mei N, Heflich RH, Chou MW & Chen T (2004) Mutations induced by the carcinogenic pyrrolizidine alkaloid riddelline in the liver cII gene of transgenic Big Blue® rats. Chem Res Toxicol, 17(6): 814-818.
283. Meyne J, Allison DC, Bose K, Jordan SW, Ridolpho PF & Smith J (1985) Hepatotoxic doses of dioxin do not damage mouse bone marrow chromosomes. Mutat Res, 157(1): 63-69.
284. Micillino JC, Coulais C, Binet S, Bottin M-C, Keith G, Moulin D & Rihn BH (2002) Lack of genotoxicity of bitumen fumes in transgenic mouse lung. Toxicology, 170(1-2): 11-20.
285. Mientjes EJ, Steenwinkel MJST, van Delft JHM, Lohman PHM & Baan RA (1996) Comparison of the X-gal- and P-gal-based systems for screening of mutant λ/lacZ phages originating from the transgenic mouse strain 40.6. Mutat Res, 360: 101-106.
286. Mientjes EJ, Luiten-Schuite A, van der Wolf E, Borsboom Y, Bergmanns A, Berends F, Lohman PHM, Baan RA & van Delft JHM (1998) DNA adducts, mutant frequencies, and mutation spectra in various organs of λ/lacZ mice exposed to ethylating agents. Environ Mol Mutagen, 31: 18-31.
287. Minowa O, Arai T, Hirano M, Monden Y, Nakai S, Fukuda M, Itoh M, Takano H, Hippou Y, Aburatani H, Masumura K, Nohmi T, Nishimura S & Noda T (2000) Mmh/Ogg1 gene inactivation results in accumulation of 8-hydroxyguanine in mice. Proc Natl Acad Sci USA, 97: 4156-4161.
288. Mirsalis JC, Provost GS, Matthews CD, Hamner RT, Schindler JE, O'Loughlin KG, MacGregor JT & Short JM (1993) Induction of hepatic mutations in lacI transgenic mice. Mutagenesis, 8: 265-271.
289. Mirsalis J, Monforte J & Winegar R (1995) Transgenic animal models for detection of in vivo mutations. Annu Rev Pharm Toxicol, 35: 145-164.
290. Mittelstaedt RA, Manjanatha MG, Shelton SD, Lyn-Cook LE, Chen JB, Aidoo A, Casciano DA & Heflich RH (1998) Comparison of the types of mutations induced by 7,12-dimethylbenz[a]anthracene in the lacI and Hprt genes of Big Blue® rats. Environ Mol Mutagen, 31: 149-156.
291. Mittelstaedt RA, Mei N, Webb PJ, Shaddock JG, Dobrovolsky VN, McGarrity LJ, Morris SM, Chen T, Beland FA, Greenlees KJ & Heflich RH (2004) Genotoxicity of malachite green and leucomalachite green in female Big Blue® B6C3F1 mice. Mutat Res, 561(1-2): 127-138.
292. - transgenic mice. Mutat Res, 414: 165-169.
293. Møller P, Wallin H, Vogel U, Autrup H, Risom L, Hald MT, Daneshvar B, Dragsted LO, Poulsen HE & Loft S (2002) Mutagenicity of 2-amino-3-methylimidazol[4,5-f]quinolme in colon and liver of Big Blue® rats: role of DNA adducts, strand breaks, DNA repair and oxidative stress. Carcinogenesis, 23(8): 1379-1385.
294. Monroe JJ, Kort KL, Miller JE, Marino DR & Skopek TR (1998) A comparative study of in vivo mutation assays: analysis of Hprt, lacI, cII/cI as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue® mice. Mutat Res, 421: 121-136.
295. Morita T, Asano N, Awogi T, Sasaki Y, Sato S, Shimada H, Sutou S, Suzuki T, Wakata A, Sofuni T & Hayashi M (1997a) Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens (groups 1, 2A and 2B): The summary report of the 6th collaborative study by CSGMT/JEMS MMS. Collaborative Study of the Micronucleus Group Test. Mammalian Mutagenicity Study Group. Mutat Res, 389(1): 3-122.
296. Morita T, Asano N, Awogi T, Sasaki Y, Sato S, Shimada H, Sutou S, Suzuki T, Wakata A, Sofuni T & Hayashi M (1997b) Erratum to "Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens (groups 1, 2A and 2B): The summary report of the 6th collaborative study by CSGMT/JEMS MMS." Mutat Res, 391: 259-267.
297. Morris HP, Velat CA, Wagner BP, Dahlgard M & Ray FE (1960) Studies of carcinogenicity in the rate of derivates of aromatic amines related to N-2-ftuorenylacetamtde. J Natl Cancer Inst, 24: 149-180.
298. Müller AK, Farombi EO, Moller P, Autrup HN, Vogel U, Wallin H, Dragsted LO, Loft S & Binderup ML (2004) DNA damage in lung after oral exposure to diesel exhaust particles in Big Blue® rats. Mutat Res, 550(1-2): 123-132.
299. Mullin AH, Rando R, Esmundo F & Mullin DA (1995) Inhalation of benzene leads to an increase in the mutant frequencies of a lacI transgene in lung and spleen tissues of mice. Mutat Res, 327: 121-129.
300. Mullin AH, Nataraj D, Ren J-J & Mullin DA (1998) Inhaled benzene increases the frequency and length of lacI deletion mutations in lung tissues of mice. Carcinogenesis, 19(10): 1723-1733.
301. Myhr B (1991) Validation studies with Muta Mouse: a transgenic mouse model for detecting mutations in vivo. Environ Mol Mutagen, 18(4): 308-315.
302. Nagao M (1999) A new approach to risk estimation of food-borne carcinogens heterocyclic amines - based on molecular information. Mutat Res, 431(1): 3-12.
303. Nagao M, Fujita H, Ochiai M, Wakabayashi K, Sofuni T, Matsushima T, Sugimura T & Ushijima T (1998) No direct correlation between mutant frequencies and cancer incidence induced by MeIQ in various organs of Big Blue® mice. Mutat Res, 400: 251-257.
304. Nagao M, Ochiai M, Okochi E, Ushijima T & Sugimura T (2001) LacI transgenic animal study: relationships among DNA-adduct levels, mutant frequencies and cancer incidences. Mutat Res, 477: 119-124.
305. Nakajima M, Kikuchi M, Saeki K, Miyata Y, Terada M, Kishida F, Yamamoto R, Furihata C & Dean SW (1999) Mutagenicity of 4-nitroquinoline 1-oxide in the Muta™Mouse. Mutat Res, 444: 321-336.
306. Neuhäuser A (1977) Die Wirksamkeit von Natulan im Fellflecken-Test mit der Maus. GSF-Ber B, 798: 42-44.
307. Neuhäuser-Klaus A & Chauhan P (1987) Studies on somatic mutation induction in the mouse with isoniazid and hydrazine. Mutat Res, 191: 111-116.
308. Neuhäuser-Klaus A & Schmahl W (1989) Mutagenic and teratogenic effects of acrylamide in the mammalian spot test. Mutat Res, 226(3): 157-162.
309. Nishino H, Buettner VL, Haavik J, Schaid DJ & Sommer SS (1996) Spontaneous mutation in Big Blue® transgenic mice: analysis of age, gender and tissue type. Environ Mol Mutagen, 28(4): 299-312.
310. Nohmi T & Masumura K (2004) gpt delta transgenic mouse: a novel approach for molecular dissection of deletion mutations in vivo. Adv Biophys, 38: 97-121.
311. Nohmi T & Masumura K (2005) Molecular nature of intrachromosomal deletions and base substitutions induced by environmental mutagens. Environ Mol Mutagen, 45: 150-161.
312. - and 6-thioguanine selections. Environ Mol Mutagen, 28: 465-470.
313. - selection: An efficient method to detect γ-ray-induced deletions in transgenic mice. Environ Mol Mutagen, 34: 9-15.
314. Nohmi T, Suzuki T & Masumura K (2000) Recent advances in the protocols of transgenic mouse mutation assays. Mutat Res, 455(1-2): 191-215.
315. NTP (2003a) 2-Acetylaminofluorene. CAS: 53-96-3. Research Triangle Park, North Carolina, United States Department of Health and Human Services, National Toxicology Program (Factsheet; http://ntp-server.niehs.nih.gov/index.cfm? objectid=6DDF4AD9-F1F6-975E-7A0747B910250667; last updated 4 September 2003; accessed 11 November 2004).
316. NTP (2003b) 2,6-Toluenediamine dihydrochloride (2,6-diaminotoluene dihydrochloride). CAS 15481-70-6. Research Triangle Park, North Carolina, United States Department of Health and Human Services, National Toxicology Program (Factsheet: http://ntp.niehs.nih.gov/index.cfm?objectid=0718C4BA-E9A2-42AB- A9634AF5BFA7D317; last updated 4 September 2003; accessed 11 November 2004).
317. Ochiai M, Ishida K, Ushijima T, Suzuki T, Sofuni T, Sugimura T & Nagao M (1998) DNA adduct level induced by 2-amino-3,4-dimethylimidazo[4,5- f]-quinoline in Big Blue® mice does not correlate with mutagenicity. Mutagenesis, 13(4): 381-384.
318. OECD (1971) OECD guideline for the testing of chemicals. OECD 486: Unscheduled DNA synthesis (UDS) test with mammalian liver cells in vivo. Paris, Organisation for Economic Co-operation and Development, pp 1-8.
319. OECD (1981) OECD guideline for the testing of chemicals. OECD 451: Carcinogenicity studies. Paris, Organisation for Economic Co-operation and Development, pp 1-17.
320. OECD (1984a) OECD guideline for the testing of chemicals. OECD 477: Genetic toxicology: Sex-linked recessive lethal test in Drosophila melanogaster. Paris, Organisation for Economic Co-operation and Development, pp 1-6.
321. OECD (1984b) OECD guideline for the testing of chemicals. OECD 478: Genetic toxicology: Rodent dominant lethal test. Paris, Organisation for Economic Co-operation and Development, pp 1-6.
322. OECD (1986a) OECD guideline for the testing of chemicals. OECD 484: Genetic toxicology: mouse spot test. Paris, Organisation for Economic Co-operation and Development, pp 1-4.
323. OECD (1986b) OECD guideline for the testing of chemicals. OECD 485: Genetic toxicology: Mouse heritable translocation assay. Paris, Organisation for Economic Co-operation and Development, pp 1-6.
324. OECD (1997a) OECD guideline for the testing of chemicals. OECD 474: Mammalian erythrocyte micronucleus test. Paris, Organisation for Economic Co-operation and Development, pp 1-10.
325. OECD (1997b) OECD guideline for the testing of chemicals. OECD 475: Mammalian bone marrow chromosome aberration test. Paris, Organisation for Economic Co-operation and Development, pp 1-8.
326. OECD (1997c) OECD guideline for the testing of chemicals. OECD 483: Mammalian spermatogonial chromosome aberration test. Paris, Organisation for Economic Co-operation and Development, pp 1-8.
327. Ohsawa K, Hirano N, Sugiura M, Nakagawa S & Kimura M (2000) Genotoxicity of o-aminoazotoluene (AAT) determined by the Ames test, the in vitro chromosomal aberration test, and the transgenic mouse gene mutation assay. Mutat Res, 471: 113-126.
328. Okada N, Honda A, Kawabata M & Yajima N (1997) Sodium phenobarbital-enhanced mutation frequency in the liver DNA of lacZ transgenic mice treated with diethylnitrosamine. Mutagenesis, 12:179-184.
329. Okochi E, Watanabe N, Shimada Y, Takahashi S, Wakazono K, Shirai T, Sugimura T, Nagao M & Ushijima T (1999) Preferential induction of guanine deletion at 5′-GGGA-3′ in rat mammary glands by 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine. Carcinogenesis, 20(10): 1933-1938.
330. Okonogi H, Stuart GR, Okochi E, Ushijima T, Sugimura T, Glickman BW & Nagao M (1997) Effects of gender and species on spectra of mutation induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the lacI transgene. Mutat Res, 395: 93-99.
331. Paashuis-Lew YR & Heddle JA (1998) Spontaneous mutation during fetal development and post-natal growth. Mutagenesis, 13(6): 613-617.
332. Paashuis-Lew Y, Zhang XB & Heddle JA (1997) On the origin of spontaneous somatic mutations and sectored plaques detected in transgenic mice. Mutat Res, 373(2): 277-284.
333. Piegorsch WW, Lockhart AC, Carr GJ, Margolin BH, Brooks T, Douglas GR, Liegibel UM, Suzuki T, Thybaud V, van Delft JHM & Gorelick NJ (1997) Sources of variability in data from a positive selection lacZ transgenic mouse mutation assay: an interlaboratory study. Mutat Res, 388: 249-289.
334. 6-methylguanine. Carcinogenesis, 18: 2191-2196.
335. Pletsa V, Steenwinkel MJ, van Delft JH, Baan RA & Kyrtopoulos SA (1999) Methyl bromide causes DNA methylation in rats and mice but fails to induce somatic mutations in lambda lacZ transgenic mice. Cancer Lett, 135(1): 21-27.
336. Provost GS & Short JM (1994) Characterization of mutations induced by ethylnitrosourea in seminiferous tubule germ cells of transgenic B6C3F1 mice. Proc Natl Acad Sci USA, 91: 6564-6568.
337. Provost GS, Kretz P, Hamner RT, Matthews CD, Rogers BJ, Lundberg KS, Dycaico MJ & Short JM (1993) Transgenic systems for in vivo mutation analysis. Mutat Res, 288: 133-149.
338. Provost GS, Mirsalis JC, Rogers BJ & Short JM (1996) Mutagenic response to benzene and tris(2,3-dibromopropyl)-phosphate in the lambda lacI transgenic mouse mutation assay: a standardized approach to in vivo mutation analysis. Environ Mol Mutagen, 28: 342-347.
339. Putman DL, Penn Ritter A, Carr GJ & Young RR (1997) Evaluation of spontaneous and chemical-induced lacI mutations in germ cells from λ/lacI transgenic mice. Mutat Res, 388: 137-143.
340. RamaKrishna NVS, Devanesan PD, Rogan EG, Cavalieri EL, Jeong H, Jankowiak R & Small GJ (1992) Mechanism of metabolic activation of the potent carcinogen 7,12-dimethylbenz[a]anthracene. Chem Res Toxicol, 5: 220-226.
341. Recio L, Bond JA, Pluta LJ & Sisk SC (1993) Use of transgenic mice for assessing the mutagenicity of 1,3-butadiene in vivo. In: Sorsa M, Peltonen K, Vainio H & Hemminki K eds. Butadiene and styrene: assessment of health hazards. Lyon, International Agency for Research on Cancer, pp 235-243 (IARC Scientific Publications No. 127).
342. Recio L, Meyer KG, Pluta LJ, Moss OR & Saranko CJ (1996) Assessment of 1,3-butadiene mutagenicity in the bone marrow of B6C3F1 lacI transgenic mice (Big Blue®): a review of mutational spectrum and lacI mutant frequency after a 5-day 625 ppm 1,3-butadiene exposure. Environ Mol Mutagen, 28: 424-429.
343. Recio L, Donner M, Abemethy D, Pluta L, Steen AM, Wong BA, James A & Preston RJ (2004) In vivo mutagenicity and mutation spectrum in the bone marrow and testes of B6C3F1 lacI transgenic mice following inhalation exposure to ethylene oxide. Mutagenesis, 19(3): 215-222.
344. Renault D, Brault D & Thybaud V (1997) Effect of ethylnitrosourea and methyl methanesulfonate on mutation frequency in Muta™Mouse germ cells (seminiferous tubule cells and epididymis spermatozoa). Mutat Res, 388: 145-153.
345. Rihn B, Coulais C, Kauffer E, Bottin M-C, Martin P, Yvon F, Vigneron JC, Binet S, Monhoven N, Steiblen G & Keith G (2000) Inhaled crocidolite mutagenicity in lung DNA. Environ Health Perspect, 108: 341-346.
346. RIVM (2000) Mutagenicity of chemicals in genetically modified animals. Bilthoven, National Institute of Public Health and the Environment (RIVM), pp 1-47 (RIVM Report No. 650210 002; TNO Report No. V99.1097).
347. Robbiano L, Mereto E, Morando AM, Pastore P & Brambilla G (1998) Increased frequency of micronucleated kidney cells in rats exposed to halogenated anaesthetics. Mutat Res, 413: 1-6.
348. Rogers BJ, Provost GS, Young RR, Putman DL & Short JM (1995) Intralaboratory optimization and standardization of mutant screening conditions used for a lambda/lacI transgenic mouse mutagenesis assay (I). Mutat Res, 327: 57-66.
349. Ross JA & Leavitt SA (1998) Induction of mutations by 2-acetylaminofluorene in lacI transgenic B6C3F1 mouse liver. Mutagenesis, 13: 173-179.
350. Russell LB, Selby PB, von Halle E, Sheridan W & Valcovic L (1981) Use of the mouse spot test in chemical mutagenesis: interpretation of past data and recommendations for future work. Mutat Res, 86: 355-379.
351. Sanger F, Coulson AR, Friedman T, Air GM, Barrell BG, Brown NL, Fiddes JC, Hutchison CA III, Slocombe PM & Smith M (1978) The nucleotide sequence of bacteriophage ΦX174. J Mol Biol, 125: 225-246.
352. Sasaki YF, Imanishi H, Watanabe M, Sekiguchi A, Moriya M, Shirasu Y & Tutikawa K (1986) Mutagenicity of 1,2-dibromo-3-chloropropane (DBCP) in the mouse spot test. Mutat Res, 174(2): 145-147.
353. Schaaper RM, Danforth BN & Glickman BW (1986) Mechanisms of spontaneous mutagenesis: an analysis of the spectrum of spontaneous mutation in the Escherichia coli lacI gene. J Mol Biol, 189(2): 273-284.
354. Schaaper RM, Koffel-Schwartz N & Fuchs RP (1990) N-Acetoxy- N-acetyl-2-aminofluorene-induced mutagenesis in the lacI gene of Escherichia coli. Carcinogenesis, 11(7): 1087-1095.
355. Schinz HR, Fritz-Niggli H, Campbell TW & Schmid H (1955) Krebsbildung durch Aminofluorene und verwandte Körper. Oncologia, 8: 233-245.
356. Schmezer P & Eckert C (1999) Induction of mutations in transgenic animal models: Big Blue® and Muta™Mouse. In: McGregor DB, Rice JM & Venitt S eds. The use of short-and medium-term tests for carcinogens and data on genetic effects in carcinogenic hazard evaluation. Lyon, International Agency for Research on Cancer, pp 367-394 (IARC Scientific Publications No. 146).
357. Schmezer P, Eckert C, Liegibel U, Zelezny O & Klein R (1998a) Mutagenic activity of carcinogens detected in transgenic rodent mutagenicity assays at dose levels used in chronic rodent cancer bioassays. Mutat Res, 405: 193-198.
358. Schmezer P, Eckert C, Liegibel U, Klein R & Bartsch H (1998b) Use of transgenic mutational test systems in risk assessment of carcinogens. Arch Toxicol Suppl, 20: 321-330.
359. Shane BS, Lockhart AM, Winston GW & Tindall KR (1997) Mutant frequency of lacI in transgenic mice following benzo[a]pyrene treatment and partial hepatectomy. Mutat Res, 377: 1-11.
360. Shane BS, de Boer J, Watson DE, Haseman JK, Glickman BW & Tidall KR (2000a) LacI mutation spectra following benzo[a]pyrene treatment of Big Blue® mice. Carcinogenesis, 21: 715-725.
361. Shane BS, Smith-Dunn DL, de Boer JG, Glickman BW & Cunningham ML (2000b) Mutant frequencies and mutation spectra of dimethylnitrosamine (DMN) at the lacI and cII loci in the livers of Big Blue® transgenic mice. Mutat Res, 452: 197-210.
362. Shane BS, Smith-Dunn DL, deBoer JG, Glickman BW & Cunningham ML (2000c) Subchronic administration of phenobarbital alters the mutation spectrum of lacI in the livers of Big Blue® transgenic mice. Mutat Res, 448: 69-80.
363. Shaver-Walker PM, Urlando C, Tao KS, Zhang XB & Heddle JA (1995) Enhanced somatic mutation rates induced in stem cells of mice by low chronic exposure to ethylnitrosourea. Proc Natl Acad Sci USA, 92: 11470-11474.
364. Shelby MD & Wilt KL (1995) Comparison of results from mouse bone marrow chromosome aberration and micronucleus tests. Environ Mol Mutagen, 25: 302-313.
365. Shelby MD, Erexson GL, Hook GJ & Tice RR (1993) Evaluation of a three-exposure mouse bone marrow micronucleus protocol: results with 49 chemicals. Environ Mol Mutagen, 21: 160-179.
366. Shelton SD, Cherry V & Manjanatha MG (2000) Mutant frequency and molecular analysis of in vivo lacI mutations in the bone marrow of Big Blue® rats treated with 7,12-dimethylbenz[a]anthracene. Environ Mol Mutagen, 36: 235-242.
367. Shephard SE, Sengstag C, Lutz WK & Schlatter C (1993) Mutations in liver DNA of lacI transgenic mice (Big Blue®) following subchronic exposure to 2-acetylaminofluorene. Mutat Res, 302: 91-96.
368. Shephard SE, Gunz D & Schlatter C (1995) Genotoxicity of agaritine in the lacI transgenic mouse mutation assay: evaluation of the health risk of mushroom consumption. Food Chem Toxicol, 33: 257-264.
369. Shibata A, Kamada N, Masumura K, Nohmi T, Kobayashi S, Teraoka H, Nakagama H, Sugimura T, Suzuki H & Masutani M (2005) Parp-1 deficiency causes an increase of deletion mutations and insertions/ rearrangements in vivo after treatment with an alkylating agent. Oncogene, 24(8): 1328-1337.
370. Shibuya T & Morimoto K (1993) A review of the genotoxicity of 1-ethyl-1-nitrosourea. Mutat Res, 297(1): 3-38.
371. Shimada H, Suzuki H, Itoh S, Hattori C, Matsuura Y, Tada S & Watanabe C (1992) The micronucleus test of benzo[a]pyrene with mouse and rat peripheral blood reticulocytes. Mutat Res, 278: 165-168.
372. Singh VK, Ganesh L, Cunningham ML & Shane BS (2001) Comparison of the mutant frequencies and mutation spectra of three non-genotoxic carcinogens, oxazepam, phenobarbital, and Weyth 14,643, at the lambdacII locus in Big Blue® transgenic mice. Biochem Pharmacol, 62(6): 685-692.
373. Sisk SC, Pluta L, Bond JA & Recio L (1994) Molecular analysis of lacI mutants from bone marrow of B6C3F1 transgenic mice following inhalation exposure to 1,3-butadiene. Carcinogenesis, 15(3): 471-477.
374. Sisk SC, Pluta LJ, Meyer KG, Wong BC & Recio L (1997) Assessment of the in vivo mutagenicity of ethylene oxide in the tissues of B6C3F1 lacI transgenic mice following inhalation exposure. Mutat Res, 391: 153-164.
375. Skopek TR, Kort KL & Marino DR (1995) Relative sensitivity of the endogenous Hprt gene and lacI transgene in ENU-treated Big Blue® B6C3F1 mice. Environ Mol Mutagen, 26: 9-15.
376. Skopek TR, Kort KL, Marino DR, Mittal LV, Umbenhauer DR, Laws GM & Adams SP (1996) Mutagenic response of the endogenous Hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue® B6C3F1 mice. Environ Mol Mutagen, 28: 376-384.
377. Slattery SD & Valentine CR (2003) Development of a microplate assay for the detection of single plaque-forming units of bacteriophage ΦX174 in crude lysates. Environ Mol Mutagen, 41: 121-125.
378. Slikker W, Mei N & Chen T (2004) N-Ethyl-N-nitrosourea (ENU) increased brain mutations in prenatal and neonatal mice but not in the adults. Toxicol Sci, 81(1): 112-120.
379. Stratagene (2002) λ Select-cII™ mutation detection system for Big Blue® rodents. Instruction manual. La Jolla, California, Stratagene, pp 1-24 (Catalogue No. 720120; http://www.stratagene.com/manuals/ 720120.pdf).
380. Stuart GR, Thorleifson E, Okochi E, de Boer JG, Ushijima T, Nagao M & Glickman BW (200Oa) Interpretation of mutational spectra from different genes: analyses of PhIP-induced mutational specificity in the lacI and cII transgenes from colon of Big Blue® rats. Mutat Res, 452: 101-121.
381. Stuart GR, Holcroft J, de Boer JG & Glickman BW (2000b) Prostate mutations in rats induced by the suspected human carcinogen 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine. Cancer Res, 60: 266-268.
382. Stuart GR, de Boer JG, Haesevoets R, Holcroft J, Kangas J, Sojonky K, Thorleifson E, Thornton A, Walsh DF, Yang H & Glickman BW (2001) Mutations induced by 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) in cecum and proximal and distal colon of lacI transgenic rats. Mutagenesis, 16(5): 431-437.
383. Styles JA & Penman MG (1985) The mouse spot test. Evaluation of its performance in identifying chemical mutagens and carcinogens. Mutat Res, 154(3): 183-204.
384. Sun B & Heddle JA (1999) The relationship between mutant frequency and time in vivo: simple predictions for any tissue, cell type, or mutagen. Mutat Res, 425: 179-183.
385. Suter W, Ahiabor R, Blanco B, Locher F, Mantovani F, Robinson M, Sreenan G, Staedtler F, Swingler T, Vignutelli A & Perentes E (1996) Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue® transgenic mouse mutation assay. Environ Mol Mutagen, 28: 354-362.
386. Suzuki T, Hayashi M, Sofuni T & Myhr BC (1993) The concomitant detection of gene mutation and micronucleus induction by mitomycin C in vivo using lacZ transgenic mice. Mutat Res, 285: 219-224.
387. Suzuki T, Hayashi M & Sofuni T (1994) Initial experiences and future directions for transgenic mouse mutation assays. Mutat Res, 307: 489-494.
388. Suzuki T, Hayashi M, Myhr B & Sofuni T (1995) Diethylnitrosamine is mutagenic in liver but not in bone marrow of lacZ transgenic mice (Muta™Mouse). Honyu Dobutsu Shiken Bunkakai Kaiho, 3(1): 33-39.
389. Suzuki T, Itoh T, Hayashi M, Nishikawa Y, Ikezaki S, Furukawa F, Takahashi M & Sofuni T (1996a) Organ variation in the mutagenicity of dimethylnitrosamine in Big Blue® mice. Environ Mol Mutagen, 28: 348-353.
390. Suzuki T, Hayashi M, Ochiai M, Wakabayashi K, Ushijima T, Sugimura T, Nagao M & Sofuni T (1996b) Organ variation in the mutagenicity of MeIQ in Big Blue® lacI transgenic mice. Mutat Res, 369: 45-49.
391. Suzuki T, Hayashi M, Wang X, Yamamoto K, Ono T, Myhr BC & Sofuni T (1997) A comparison of the genotoxicity of ethylnitrosourea and ethyl methanesulfonate in lacZ transgenic mice (Muta™Mouse). Mutat Res, 395: 75-82.
392. Suzuki T, Miyata Y, Saeki K, Kawazoe Y, Hayashi M & Sofuni T (1998) In vivo mutagenesis by the hepatocarcinogen quinoline in the lacZ transgenic mouse: evidence for its in vivo genotoxicity. Mutat Res, 412: 161-166.
393. Suzuki T, Itoh S, Nakajima M, Hachiya N & Hara T (1999a) Target organ and time-course in the mutagenicity of five carcinogens in Muta™Mouse: a summary report of the second collaborative study of the transgenic mouse mutation assay by the JEMS/MMS. Mutat Res, 444: 259-268.
394. Suzuki T, Uno Y, Idehara K, Baba T, Maniwa J, Ohkouchi A, Wang X, Hayashi M, Sofuni T, Tsuruoka M, Miyajima H & Kondo K (1999b) Procarbazine genotoxicity in the Muta™Mouse; strong clastogenicity and organ-specific induction of lacZ mutations. Mutat Res, 444: 269-281.
395. Swiger RR (2001) Just how does the cII selection system work in Muta Mouse? Environ Mol Mutagen, 37(4): 290-296.
396. Swiger RR, Cosentino L, Shima N, Bielas JH, Cruz-Munoz W & Heddle JA (1999) The cII locus in the Muta™Mouse system. Environ Mol Mutagen, 34: 201-207.
397. Sykes PJ, Hooker AM, Jacobs AK, Harrington CS, Kingsbury L & Morley AA (1998) Induction of somatic intrachromosomal recombination inversion events by cyclophosphamide in a transgenic mouse model. Mutat Res, 397: 209-219.
398. Sykes PJ, Hooker AM & Morley AA (1999) Inversion due to intrachromosomal recombination produced by carcinogens in a transgenic mouse model. Mutat Res, 427: 1-9.
399. Sykes PJ, McCallum BD, Bangay MJ, Hooker AM & Morley AA (2001) Effect of 900 MHz radiofrequency radiation exposure on intrachromosomal recombination in pKZ1 mice. Radiat Res, 156: 495-502.
400. Takeiri A, Mishima M, Tanaka K, Shioda A, Ueda O, Suzuki H, Inoue M, Masumura K & Nohmi T (2003) Molecular characterization of mitomycin C-induced large deletions and tandem-base substitution in the bone marrow of gpt delta transgenic mice. Chem Res Toxicol, 16: 171-179.
401. Tao KS, Urlando C & Heddle JA (1993a) Comparison of somatic mutations in a transgenic versus host locus. Proc Natl Acad Sci USA, 90: 10681-10685.
402. Tao KS, Urlando C & Heddle JA (1993b) Mutagenicity of methyl methanesulfonate (MMS) in vivo at the Dlb-1 native locus and a lacI transgene. Environ Mol Mutagen, 22: 293-296.
403. Thompson ED & Osterhues MA (1995) Effect of expression period on dimethylbenzanthracene-induced mutations in skin of Big Blue® mice. Abstr Annu Meet Environ Mutagen Soc, 1995: 52.
404. Thornton AS, Oda Y, Stuart GR, Glickman BW & de Boer JG (2001) Mutagenicity of TCDD in Big Blue transgenic rats. Mutat Res, 478(1-2): 45-50.
405. Thybaud V, Dean S, Nohmi T, de Boer J, Douglas GR, Glickman BW, Gorelick NJ, Heddle JA, Heflich RH, Lambert I, Martus HJ, Mirsalis JC, Suzuki T & Yajima N (2003) In vivo transgenic mutation assays. Mutat Res, 540(2): 141-151.
406. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu J-C & Sasaki YF (2000) Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen, 35: 206-221.
407. - transgenic mutation assay to DMN: Comparison with the corresponding Big Blue® (lacI) responses. Mutat Res, 307: 169-173.
408. Tinwell H, Lefevre PA & Ashby J (1994b) Mutation studies with dimethyl nitrosamine in young and old lacI transgenic mice. Mutat Res, 307: 501-508.
409. Tinwell H, Lefevre PA & Ashby J (1998) Relative activities of methyl methanesulphonate (MMS) as a genotoxin, clastogen and gene mutagen to the liver and bone marrow of Muta™Mouse mice. Environ Mol Mutagen, 32: 163-172.
410. Tombolan F, Renault D, Brault D, Guffroy M, Périn F & Thybaud V (1999a) Effect of mitogenic or regenerative cell proliferation on lacZ mutant frequency in the liver of Muta™Mice treated with 5,9-dimethyldibenzo[c,g]carbazole. Carcinogenesis, 20: 1357-1362.
411. Tombolan F, Renault D, Brault D, Guffroy M, Perin-Roussel O, Perin F & Thybaud V (1999b) Kinetics of induction of DNA adducts, cell proliferation and gene mutations in the liver of Muta™Mice treated with 5,9-dimethyldibenzo[c,g]carbazole. Carcinogenesis, 20(1): 125-132.
412. Topinka J, Oesterle D, Reimann R & Wolff T (2004a) No-effect level in the mutagenic activity of the drug cyproterone acetate in rat liver. Part I: Single dose treatment. Mutat Res, 550(1-2): 89-99.
413. Topinka J, Oesterle D, Reimann R & Wolff T (2004b) No-effect level in the mutagenic activity of the drug cyproterone acetate in rat liver. Part II: Multiple dose treatment. Mutat Res, 550(1-2): 101-108.
414. Topinka J, Loli P, Georgiadis P, Dusinska M, Hurbankova M, Kovacikova Z, Volkovova K, Kazimirova A, Barancokova M, Tatrai E, Oesterle D, Wolff T & Kyrtopoulos SA (2004c) Mutagenesis by asbestos in the lung of λ-lacI transgenic rats. Mutat Res, 553(1-2): 67-78.
415. Trzos RJ, Petzold GL, Brunden MN & Swenberg JA (1978) The evaluation of sixteen carcinogens in the rat using the micronucleus test. Mutat Res, 58: 79-86.
416. Tsutsui Y, Tsukidate K & Hakura A (1999) Sequence of the lacZ transgene of the Muta™Mouse. Environ Mutagen Res Commun, 21: 39-43.
417. Tucker JD, Carrano AV, Allen NA, Christensen ML, Knize MG, Strout CL & Felton JS (1989) In vivo cytogenetic effects of cooked food mutagens. Mutat Res, 224(1): 105-113.
418. Turner SD, Tinwell H, Piegorsch W, Schmezer P & Ashby J (2001) The male rat carcinogens limonene and sodium saccharin are not mutagenic to male Big Blue rats. Mutagenesis, 16(4): 329-332.
419. Tweats DJ & Gatehouse DG (1988) Further debate of testing strategies. Mutagenesis, 3(2): 95-102.
420. Ushijima T, Hosoya Y, Ochiai M, Kushida H, Wakabayashi K, Suzuki T, Hayashi M, Sofuni T, Sugimura T & Nagao M (1994) Tissue-specific mutational spectra of 2-amino-3,4-dimethylimidazo[4,5-f]quinoline in the liver and bone marrow of lacI transgenic mice. Carcinogenesis, 15: 2805-2809.
421. Valentine CR, Montgomery BA, Miller SG, Delongchamp RR, Fane BA & Malling HV (2002) Characterization of mutant spectra generated by a forward mutational assay for gene A of ΦX174 from ENU-treated transgenic mouse embryonic cell line PX-2. Environ Mol Mutagen, 39: 55-68.
422. Valentine CR, Raney JL, Shaddock JG, Dobrovolsky VN & Delongchamp RR (2004) In vivo mutation in gene A of splenic lymphocytes from ΦX174 transgenic mice. Environ Mol Mutagen, 44: 128-150.
423. van Delft JH, Bergmans A, van Dam FJ, Tates AD, Howard L, Winton DJ & Baan RA (1998) Gene-mutation assay in lambda lacZ transgenic mice: comparison of lacZ with endogenous genes in splenocytes and small intestinal epithelium. Mutat Res, 415: 85-96.
424. van Oostrom CT, Boeve M, van Den Berg J, de Vries A, Dolle ME, Beems RB, van Kreijl CF, Vijg J & van Steeg H (1999) Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice. Environ Mol Mutagen, 34: 124-130.
425. van Sloun PPH, Wijnhoven SWP, Kool HJM, Slater R, Weeda G, Van Zeeland AA, Lohman PHM & Vrieling H (1998) Determination of spontaneous loss of heterozygosity mutations in Aprt heterozygous mice. Nucleic Acids Res, 26(21): 4888-4894.
426. Vijayalaxmi KK & Rai SP (1996) Studies on the genotoxicity of tamoxifen citrate in mouse bone marrow cells. Mutat Res, 368(2): 109-114.
427. Vijg J & Douglas GR (1996) Bacteriophage lambda and plasmid lacZ transgenic mice for studying mutations in vivo. In: Pfeifer GP ed. Technologies for detection of DNA damage and mutations. New York, Plenum Press, pp 391-410.
428. Vijg J, Dolle ME, Martus HJ & Boerrigter ME (1997) Transgenic mouse models for studying mutations in vivo: applications in aging research. Mech Ageing Dev, 99: 257-271.
429. Vogel U, Thein N, Moller P & Wallin H (2001) Pharmacological coal tar induces G:C to T:A transversion mutations in the skin of Muta Mouse. Pharmacol Toxicol, 89(1): 30-34.
430. von Pressentin MdM, Kosinska W & Guttenplan JB (1999) Mutagenesis induced by oral carcinogens in lacZ mouse (Muta™Mouse) tongue and other oral tissues. Carcinogenesis, 20: 2167-2170.
431. Wahnschaffe U, Bitsch A, Kielhorn J & Mangelsdorf I (2005a) Mutagenicity testing with transgenic mice. Part I: Comparison with the mouse bone marrow micronucleus test. J Carcinogen, 4(3): 1-14.
432. Wahnschaffe U, Bitsch A, Kielhom J & Mangelsdorf I (2005b) Mutagenicity testing with transgenic mice. Part II: Comparison with the mouse spot test. J Carcinogen, 4(4): 1-8.
433. Walker VE, Gorelick NJ, O'Kelly JA, Craft TR, de Boer J, Glickman BW & Skopek TR (1994) Frequency and spectrum of ethylnitrosourea induced mutation at the Hprt and lacI loci in splenic T-cells of exposed Big Blue® mice. Environ Mol Mutagen Suppl, 23: 71.
434. Walker VE, Sisk SC, Upton PB, Wong BA & Recio L (1997) In vivo mutagenicity of ethylene oxide at the hprt locus in T-lymphocytes of B6C3F1 lacI transgenic mice following inhalation exposure. Mutat Res, 392: 211-222.
435. Walker VE, Andrews JL, Upton PB, Skopek TR, deBoer JG, Walker DM, Shi X, Sussman HE & Gorelick NJ (1999a) Detection of cyclophosphamide-induced mutations at the Hprt but not the lacI locus in splenic lymphocytes of exposed mice. Environ Mol Mutagen, 34: 167-181.
436. Walker VE, Jones IM, Crippen TL, Meng Q, Walker DM, Bauer MJ, Reilly AA, Tates AD, Nakamura J, Upton PB & Skopek TR (1999b) Relationship between exposure, cell loss and proliferation, and manifestation of Hprt mutant T cells following treatment of preweanling, weanling, and adult male mice with N-ethyl-N-nitrosourea. Mutat Res, 431: 371-388.
437. Wang J, Liu X, Heflich RH & Chen T (2004) Time course of cII gene mutant manifestation in the liver, spleen, and bone marrow of N-ethyl-N-nitrosourea-treated Big Blue® transgenic mice. Toxicol Sci, 82(1): 124-128.
438. Wang X, Suzuki T, Itoh T, Honma M, Nishikawa A, Furukawa F, Takahashi M, Hayashi M, Kato T & Sofuni T (1998) Specific mutational spectrum of dimethylnitrosamine in the lacI transgene of Big Blue® C57BL/6 mice. Mutagenesis, 13: 625-630.
439. Wang Y & Heddle JA (2004) Spontaneous and induced chromosomal damage and mutations in Bloom Syndrome mice. Mutat Res, 554(1-2): 131-137.
440. Wijnhoven SW & van Steeg H (2003) Transgenic and knockout mice for DNA repair functions in carcinogenesis and mutagenesis. Toxicology, 193: 171-187.
441. Wild D, Gocke E, Harnasch D, Kaiser G & King MT (1985) Differential mutagenic activity of IQ (2-amino-3-methylimidazo[4,5-f]quinoline) in Salmonella typhimurium strains in vitro and in vivo, in Drosophila, and in mice. Mutat Res, 156: 93-102.
442. - transgenic mice. Mutagenesis, 13: 133-137.
443. Winegar RA, Carr G & Mirasalis JC (1997) Analysis of the mutagenic potential of ENU and MMS in germ cells of male C57BL/6 lacI transgenic mice. Mutat Res, 388: 175-178.
444. Winton DJ, Blount MA & Ponder BAJ (1988) A clonal marker induced by mutation in mouse intestinal epithelium. Nature, 333: 463-466.
445. Winton DJ, Gooderham NJ, Boobos AR, Davies DS & Ponder BAJ (1990) Mutagenesis of mouse intestine in vivo using the Dlb-1 specific locus test: studies with 1,2-dimethylhydrazine, dimethylnitrosamine, and the dietary mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Cancer Res, 50: 7992-7996.
446. Wolff T, Topinka J, Demi E, Oesterle D & Schwarz LR (2001) Dose dependent induction of DNA adducts, gene mutations and cell proliferation by the antiandrogenic drug cyproterone acetate in rat liver. Adv Exp Med Biol, 500: 678-696.
447. Yamada K, Suzuki T, Kohara A, Hayashi M, Mizutani T & Saeki K (2004) In vivo mutagenicity of benzo[f]quinoline, benzo[h]quinoline, and 1,7-phenanthroline using the lacZ transgenic mice. Mutat Res, 559(1-2): 83-95.
448. Yang H, Glickman B & de Boer JG (2002) Sex-specific induction of mutations by PhIP in the kidney of male and female rats and its modulations by conjugated linoleic acid. Environ Mol Mutagen, 40(2): 116-121.
449. Yatagai F, Kurobe T, Nohmi T, Masumura K, Tsukada T, Yamaguchi H, Kasai-Eguchi K & Fukunishi N (2002) Heavy-ion-induced mutations in the gpt delta transgenic mouse: Effect of p53 gene knockout. Environ Mol Mutagen, 40: 216-225.
450. Zhang XB, Felton JS, Tucker JD, Urlando C & Heddle JA (1996) Intestinal mutagenicity of two carcinogenic food mutagens in transgenic mice: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and amino(α) carboline. Carcinogenesis, 17: 2259-2265.
451. Zimmer DM, Harbach PR, Mattes WB & Aaron CS (1999) Comparison of mutant frequencies at the transgenic λ LacI and cII/cI loci in control and ENU-treated Big Blue® mice. Environ Mol Mutagen, 33: 249-256.